<SEC-DOCUMENT>0001140361-25-038671.txt : 20251020
<SEC-HEADER>0001140361-25-038671.hdr.sgml : 20251020
<ACCEPTANCE-DATETIME>20251020161931
ACCESSION NUMBER:		0001140361-25-038671
CONFORMED SUBMISSION TYPE:	424B3
PUBLIC DOCUMENT COUNT:		15
FILED AS OF DATE:		20251020
DATE AS OF CHANGE:		20251020

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			TORONTO DOMINION BANK
		CENTRAL INDEX KEY:			0000947263
		STANDARD INDUSTRIAL CLASSIFICATION:	COMMERCIAL BANKS, NEC [6029]
		ORGANIZATION NAME:           	02 Finance
		EIN:				135640479
		STATE OF INCORPORATION:			A6
		FISCAL YEAR END:			1031

	FILING VALUES:
		FORM TYPE:		424B3
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-283969
		FILM NUMBER:		251404056

	BUSINESS ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
		BUSINESS PHONE:		416-944-6367

	MAIL ADDRESS:	
		STREET 1:		66 WELLINGTON STREET WEST
		STREET 2:		12TH FLOOR, TD TOWER
		CITY:			TORONTO, ONTARIO
		STATE:			A6
		ZIP:			M5K 1A2
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B3
<SEQUENCE>1
<FILENAME>ef20057439_424b3.htm
<DESCRIPTION>PRICING SUPPLEMENT
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using Broadridge PROfile 25.10.1.5333
         Copyright 1995 - 2025 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: Arial; font-size: 9pt; text-align: left; color: #000000;">
  <div class="BRPFPageHeader" style="width: 100%;"></div>
  <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">
  <div>
    <div>
      <div style="color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; color: #000000; width: 100%;" id="z160ebc74f35d4abbbb352fa521acf18a">

            <tr>
              <td style="width: 50.00%;">
                <div style="text-align: left;"><img width="57" height="47" src="image0.jpg"></div>
              </td>
              <td style="width: 50.00%;">
                <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">Filed Pursuant to Rule 424(b)(3)</div>
                <div style="text-align: right; margin-bottom: 10pt; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">Registration Statement No. 333-283969</div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <table cellspacing="0" cellpadding="4" border="0" id="zd3589c2714434c3c9b229a82e00891b0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="background-color: #000000; vertical-align: top; width: 99.88%;"><br>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; font-size: 8.5pt;">
      <div>Amendment No. 1 dated October 20, 2025&#8224; to the</div>
    </div>
    <div style="text-align: justify; font-size: 8.5pt;">Pricing Supplement dated October 16, 2025 to the</div>
    <div style="text-align: justify; font-size: 8.5pt;">Product Supplement MLN-EI-1 dated February 26, 2025,</div>
    <div style="text-align: justify; font-size: 8.5pt;">Underlier Supplement dated February 26, 2025 and</div>
    <div style="text-align: justify; color: rgb(0, 0, 0); font-size: 8.5pt;">Prospectus dated February 26, 2025</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z25f72387655f491dbb1e9281b18bfb48" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 99.88%; vertical-align: top; border-width: 4px; border-style: solid; border-color: rgb(0, 176, 80);">
            <div style="text-align: center; color: rgb(0, 176, 80); font-size: 16pt;">The Toronto-Dominion Bank</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">$62,000</div>
            <div style="text-align: center; color: rgb(0, 0, 0); font-size: 10pt;">Leveraged Barrier Notes Linked to the Least Performing of the Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
            <div style="margin: 0px 0px 6pt; color: #000000; font-size: 10pt; text-align: center;">and the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index Due October 21, 2030</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 3pt; font-size: 8pt;">The Toronto-Dominion Bank (&#8220;TD&#8221; or &#8220;we&#8221;) has offered the Leveraged Barrier Notes (the &#8220;Notes&#8221;) linked to the least performing of the Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>,
      the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (each, a &#8220;Reference Asset&#8221; and together, the &#8220;Reference Assets&#8221;).</div>
    <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt;">The Notes provide 168.00% leveraged participation in the positive return of the Least Performing Reference Asset if the value of <font style="font-style: italic;">each</font>
      Reference Asset increases from its Initial Value to its Final Value. The &#8220;Least Performing Reference Asset&#8221; is the Reference Asset with the lowest Percentage Change (the &#8220;Least Performing Percentage Change&#8221;). The &#8220;Percentage Change&#8221; for each
      Reference Asset is the quotient, expressed as a percentage, of (i) its Final Value <font style="font-style: italic;">minus</font> its Initial Value <font style="font-style: italic;">divided</font> by (ii) its Initial Value.</div>
    <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt;">Investors will receive their Principal Amount at maturity if the Final Value of <font style="font-style: italic;">any</font> Reference Asset is <font style="font-style: italic;">less





        than or equal to</font> its Initial Value, but the Final Value of <font style="font-style: italic;">each</font> Reference Asset is <font style="font-style: italic;">greater than or equal to</font> its Barrier Value, which is equal to 70.00% of
      its Initial Value.</div>
    <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt;">If, however, the Final Value of <font style="font-style: italic;">any</font> Reference Asset is <font style="font-style: italic;">less than</font> its Barrier Value, investors will
      suffer a percentage loss on their initial investment that is equal to the Least Performing Percentage Change, and may lose their entire Principal Amount. <font style="font-weight: bold; font-style: italic;">Specifically, investors will lose 1% of
        the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount. Any payment on the Notes is subject to our credit risk.</font></div>
    <table cellspacing="0" cellpadding="1" border="0" id="z4aacd05c3bda48ca8369c47eac3721fa" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 0%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 100%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="font-size: 8pt; font-weight: bold; text-align: justify;">Investors are exposed to the market risk of each Reference Asset on the Final Valuation Date and any decline in the value of one Reference Asset will not be offset or
              mitigated by a lesser decline or potential increase in the value of any other Reference Asset. The Payment at Maturity will be greater than the Principal Amount only if the Final Value of each Reference Asset is greater than its Initial
              Value. The Notes do not guarantee the return of the Principal Amount and investors may lose up to their entire investment in the Notes if the Final Value of any Reference Asset is less than its Barrier Value. Any payment on the Notes is
              subject to our credit risk.</div>
          </td>
          <td style="width: 0%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div style="margin: 3pt 0px 2pt; font-size: 8pt; text-align: justify;">The Notes are unsecured and are not savings accounts or insured deposits of a bank. The Notes are not insured or guaranteed by the Canada Deposit Insurance Corporation, the U.S.
      Federal Deposit Insurance Corporation or any other governmental agency or instrumentality of Canada or the United States. The Notes will not be listed or displayed on any securities exchange or electronic communications network.</div>
    <div style="text-align: justify; margin-bottom: 2pt; font-size: 8pt; font-weight: bold;">The Notes have complex features and investing in the Notes involves a number of risks. See &#8220;Additional Risk Factors&#8221; beginning on page P-6 of this pricing
      supplement, &#8220;Additional Risk Factors Specific to the Notes&#8221; beginning on page PS-7 of the product supplement MLN-EI-1 dated February 26, 2025 (the &#8220;product supplement&#8221;) and &#8220;Risk Factors&#8221; on page 1 of the prospectus dated February 26, 2025 (the
      &#8220;prospectus&#8221;).</div>
    <div style="text-align: justify; margin-bottom: 2pt; font-size: 8pt; font-weight: bold;">Neither the Securities and Exchange Commission (the &#8220;SEC&#8221;) nor any state securities commission has approved or disapproved of these Notes or determined that this
      pricing supplement, the product supplement, the underlier supplement or the prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</div>
    <div style="text-align: justify; margin-bottom: 2pt; font-size: 8pt;">We will deliver the Notes in book-entry only form through the facilities of The Depository Trust Company on the Issue Date against payment in immediately available funds.</div>
    <div style="text-align: justify; margin-bottom: 6pt; font-size: 8pt;">The estimated value of your Notes at the time the terms of your Notes were set on the Pricing Date was $927.20 per Note, as discussed further under &#8220;Additional Risk Factors &#8212; Risks
      Relating to Estimated Value and Liquidity&#8221; beginning on page P-7 and &#8220;Additional Information Regarding the Estimated Value of the Notes&#8221; on page P-20 of this pricing supplement. The estimated value is less than the public offering price of the Notes.</div>
    <table cellspacing="0" cellpadding="0" border="0" id="zcfd3fa2fb302415fac98ccaea453bfde" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 19%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">&#160;</td>
          <td style="width: 27.38%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt; font-weight: bold;">Public Offering Price</div>
          </td>
          <td style="width: 27.38%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt; font-weight: bold;">Underwriting Discount<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
          </td>
          <td style="width: 27.39%; vertical-align: top; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt; font-weight: bold;">Proceeds to TD<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
          </td>
        </tr>
        <tr>
          <td style="width: 19%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">Per Note</div>
          </td>
          <td style="width: 27.38%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">$1,000.00</div>
          </td>
          <td style="width: 27.38%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">$1.8145*</div>
          </td>
          <td style="width: 27.39%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">$998.1855*</div>
          </td>
        </tr>
        <tr>
          <td style="width: 19%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">Total</div>
          </td>
          <td style="width: 27.38%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">$62,000.00</div>
          </td>
          <td style="width: 27.38%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">$112.50</div>
          </td>
          <td style="width: 27.39%; vertical-align: top; border-top: #D9D9D9 1px solid; border-bottom: #D9D9D9 1px solid;">
            <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 0, 0); font-size: 8pt;">$61,887.50</div>
          </td>
        </tr>

    </table>
    <div> </div>
    <div>
      <div style="text-align: justify; margin-bottom: 3pt; font-size: 7pt;">* Rounded to the nearest hundredth of a cent.</div>
      <div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" id="zc497c504b76640f583bf3c857ed44bbb" style="font-family: Arial; font-size: 9pt; width: 100%;">

            <tr style="vertical-align: top;">
              <td style="text-align: right; vertical-align: top; width: 9pt;">
                <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt;"><sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">1</sup></div>
              </td>
              <td style="text-align: left; vertical-align: top; width: auto;">
                <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt;">TD Securities (USA) LLC (&#8220;TDS&#8221;) will receive a commission of up to $11.25 (1.125%) per Note with respect to a portion of the Notes and will use all of that commission to
                  allow selling concessions to other dealers in connection with the distribution of the Notes. Such other dealers may resell the Notes to other securities dealers at the Principal Amount less a concession not in excess of $11.25 per Note.
                  The total &#8220;Underwriting Discount&#8221; and &#8220;Proceeds to TD&#8221; specified above reflect the aggregate of the underwriting discount at the time TD established any hedge positions on or prior to the Pricing Date, which was variable and fluctuated
                  depending on market conditions at such times. TD will also periodically pay one or more unaffiliated dealers a structuring fee and/or marketing fee of $11.25 per Note with respect to $52,000.00 aggregate Principal Amount of the Notes. TD
                  will reimburse TDS for certain expenses in connection with its role in the offer and sale of the Notes, and TD will pay TDS a fee in connection with its role in the offer and sale of the Notes. See &#8220;Supplemental Plan of Distribution
                  (Conflicts of Interest)&#8221; herein.</div>
              </td>
            </tr>

        </table>
      </div>
      <div style="text-align: justify; margin-bottom: 3pt; font-size: 8pt;">The public offering price, underwriting discount and proceeds to TD listed above relate to the Notes we issue initially. We may decide to sell additional Notes after the date of
        this pricing supplement, at public offering prices and with underwriting discounts and proceeds to TD that differ from the amounts set forth above. The return (whether positive or negative) on your investment in the Notes will depend in part on the
        public offering price you pay for such Notes.</div>
      <div style="font-size: 8pt; text-align: justify;">&#8224; This amended and restated pricing supplement amends, restates and supersedes the pricing supplement related hereto dated October 16, 2025 in its entirety. We refer to this amended and restated
        pricing supplement as the pricing supplement.</div>
    </div>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">1</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" id="z0c159beec8cf4888afb31d09e69ee008" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 48.33%; vertical-align: middle;">&#160;</td>
          <td style="width: 51.67%; vertical-align: middle;">
            <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">Leveraged Barrier Notes Linked to the Least Performing of the Dow</div>
            <div style="text-align: right; color: rgb(0, 0, 0); font-size: 8pt; font-weight: bold;">Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
            <div style="margin: 0px 0px 6pt; color: #000000; font-size: 8pt; font-weight: bold; text-align: right;">Index Due October 21, 2030</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="4" border="0" id="z38dd79ca03f64a7b8cd48588c87773a7" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="background-color: #000000; vertical-align: top; width: 99.88%;">&#160;</td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 18pt; margin-bottom: 6pt; color: rgb(0, 176, 80); font-size: 16pt;">Summary</div>
    <div style="text-align: justify; margin-bottom: 6pt;">The information in this &#8220;Summary&#8221; section is qualified by the more detailed information set forth in this pricing supplement, the product supplement, the underlier supplement and the prospectus.</div>
    <table cellspacing="0" cellpadding="4" border="0" id="zcb93dbe860b14a2bb27d4a83e40b4e65" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 25%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issuer:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">TD</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issue:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">Senior Debt Securities, Series H</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Type of Note:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">Leveraged Barrier Notes</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Term:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">Approximately 5 years</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Reference Assets:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">The Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (Bloomberg ticker: INDU, &#8220;INDU&#8221;), the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (Bloomberg ticker: NDX, &#8220;NDX&#8221;) and the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index
              (Bloomberg ticker: RTY, &#8220;RTY&#8221;)</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">CUSIP / ISIN:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">89115HXB8 / US89115HXB85</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Agent:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">TDS</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Currency:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">U.S. Dollars</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Minimum Investment:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">$1,000 and minimum denominations of $1,000 in excess thereof</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Principal Amount:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">$1,000 per Note</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Pricing Date:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 2pt;">October 16, 2025</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Issue Date:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 2pt;">October 21, 2025, which is the third DTC settlement day following the Pricing Date. Under Rule 15c6-1 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), trades in the
              secondary market generally are required to settle in one DTC settlement day (&#8220;T+1&#8221;), unless the parties to a trade expressly agree otherwise. Accordingly, purchasers who wish to trade the Notes in the secondary market on any date prior to one
              DTC settlement day before delivery of the Notes will be required, by virtue of the fact that each Note initially will settle in three DTC settlement days (&#8220;T+3&#8221;), to specify alternative settlement arrangements to prevent a failed settlement
              of the secondary market trade.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Final Valuation Date:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify;">October 16, 2030, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Maturity Date:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 2pt;">October 21, 2030, subject to postponement upon the occurrence of a market disruption event as described in the accompanying product supplement.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">2</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <table cellspacing="0" cellpadding="4" border="0" id="za10951e53d0342738159b69f5cb1cc68" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 25%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Payment at Maturity:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">For each Note, we will pay you on the Maturity Date an amount in cash equal to:</div>
            <div style="text-align: justify; text-indent: -13.5pt; margin-left: 13.85pt; margin-bottom: 6pt;">&#8226;<font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 6.75pt;">&#160; &#160;&#160; </font>If the Final Value of <font style="font-style: italic;">each</font>
              Reference Asset is <font style="font-style: italic;">greater than</font> its Initial Value:</div>
            <div style="text-align: center; margin-left: 13.55pt; margin-bottom: 6pt;">Principal Amount + (Principal Amount &#215; Least Performing Percentage Change &#215; Leverage Factor)</div>
            <div style="text-align: justify; text-indent: -13.5pt; margin-left: 13.85pt; margin-bottom: 6pt;">&#8226;<font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 6.75pt;">&#160; &#160; </font>If the Final Value of <font style="font-style: italic;">any</font>
              Reference Asset is <font style="font-style: italic;">less than or equal to</font> its Initial Value, but the Final Value of <font style="font-style: italic;">each</font> Reference Asset is <font style="font-style: italic;">greater than or
                equal to</font> its Barrier Value:</div>
            <div style="text-align: center; margin-left: 13.55pt; margin-bottom: 6pt;">Principal Amount</div>
            <div style="text-align: justify; text-indent: -13.5pt; margin-left: 13.85pt; margin-bottom: 6pt;">&#8226;<font class="TRGRRTFtoHTMLTab" style="text-indent: 0px; font-size: 6.75pt;">&#160;&#160;&#160;&#160; </font>If the Final Value of <font style="font-style: italic;">any</font>
              Reference Asset is <font style="font-style: italic;">less than</font> its Barrier Value:</div>
            <div style="text-align: center; margin-bottom: 6pt;">Principal Amount + (Principal Amount &#215; Least Performing Percentage Change)</div>
            <div style="text-align: justify; margin-bottom: 6pt; font-style: italic; font-weight: bold;">If the Final Value of any Reference Asset is less than its Barrier Value, investors will suffer a percentage loss on their initial investment that is
              equal to the Least Performing Percentage Change. Specifically, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose
              the entire Principal Amount. Any payment on the Notes is subject to our credit risk.</div>
            <div style="text-align: justify; margin-bottom: 6pt;">All amounts used in or resulting from any calculation relating to the Payment at Maturity will be rounded upward or downward, as appropriate, to the nearest cent.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Percentage Change:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">For each Reference Asset, the Percentage Change is the quotient, expressed as a percentage, of the following formula:</div>
            <div style="text-align: center;"><u>Final Value &#8211; Initial Value</u></div>
            <div style="text-align: center; margin-bottom: 6pt;">Initial Value</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt; font-weight: bold;">Initial Value:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt;">With respect to INDU: 45,952.24</div>
            <div style="margin-bottom: 6pt;">With respect to NDX: 24,657.24</div>
            <div style="margin-bottom: 6pt;">With respect to RTY: 2,467.015</div>
            <div style="margin-bottom: 6pt;">The Initial Value of each Reference Asset equals its Closing Value on the Pricing Date, as determined by the Calculation Agent.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt; font-weight: bold;">Closing Value:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">For each Reference Asset (or any &#8220;successor index&#8221; thereto, as defined in the product supplement) on any Trading Day, the Closing Value will be its closing value published by its sponsor
              (its &#8220;Index Sponsor&#8221;) as displayed on the relevant Bloomberg Professional<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> service (&#8220;Bloomberg&#8221;) page or any successor page or service.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt; font-weight: bold;">Final Value:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">For each Reference Asset, the Closing Value of such Reference Asset on its Final Valuation Date.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt; font-weight: bold;">Barrier Value:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt;">With respect to INDU: 32,166.568 (70.00% of its Initial Value).</div>
            <div style="margin-bottom: 6pt;">With respect to NDX: 17,260.068 (70.00% of its Initial Value).</div>
            <div style="margin-bottom: 6pt;">With respect to RTY: 1,726.9105 (70.00% of its Initial Value).</div>
            <div style="margin-bottom: 6pt;">The Barrier Value for each Reference Asset is determined by the Calculation Agent.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="font-weight: bold;">Least Performing Reference</div>
            <div style="margin-bottom: 6pt; font-weight: bold;">Asset:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt; text-align: justify;">The Reference Asset with the lowest Percentage Change as compared to the Percentage Change of any other Reference Asset.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="font-weight: bold;">Least Performing Percentage</div>
            <div style="margin-bottom: 6pt; font-weight: bold;">Change:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt;">The Percentage Change of the Least Performing Reference Asset.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt; font-weight: bold;">Leverage Factor:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-bottom: 6pt;">168.00%</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-top: 3pt; margin-bottom: 3pt; font-weight: bold;">Monitoring Period:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="margin-top: 3pt; margin-bottom: 3pt;">Final Valuation Date Monitoring</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">3</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <table cellspacing="0" cellpadding="4" border="0" id="z2e8a4de96b4f4f9ba2d541fd1cf202b4" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 25%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Trading Day:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">A day on which the NYSE and the Nasdaq Stock Market, or their successors, are scheduled to be open for trading, as determined by the Calculation Agent.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Business Day:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">Any day that is a Monday, Tuesday, Wednesday, Thursday or Friday that is neither a legal holiday nor a day on which banking institutions are authorized or required by law to close in New
              York City.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">U.S. Tax Treatment:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify;">By purchasing the Notes, you agree, in the absence of a statutory or regulatory change or an administrative determination or judicial ruling to the contrary, to treat the Notes, for U.S. federal income tax
              purposes, as prepaid derivative contracts with respect to the Reference Assets. Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is of the opinion that
              it would be reasonable to treat the Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is possible that your Notes could alternatively be treated for tax
              purposes as a single contingent payment debt instrument, or pursuant to some other characterization, such that the timing and character of your income from the Notes could differ materially and adversely from the treatment described above, as
              discussed further under &#8220;Material U.S. Federal Income Tax Consequences&#8221; herein and in the product supplement.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Canadian Tax Treatment:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">Please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; and in the product supplement under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221;, which
              applies to the Notes. We will not pay any additional amounts as a result of any withholding required by reason of the rules governing hybrid mismatch arrangements contained in section 18.4 of the Canadian Tax Act (as defined in the
              prospectus).</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Calculation Agent:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">TD</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Listing:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">The Notes will not be listed or displayed on any securities exchange or electronic communications network.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 5pt; font-weight: bold;">Canadian Bail-in:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">The Notes are not bail-inable debt securities (as defined in the prospectus) under the Canada Deposit Insurance Corporation Act.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 25%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 5pt; font-weight: bold;">Change in Law Event:</div>
          </td>
          <td style="width: 75%; vertical-align: top; border-top: 1px solid rgb(217, 217, 217); border-bottom: 1px solid rgb(217, 217, 217);">
            <div style="text-align: justify; margin-bottom: 6pt;">Not applicable, notwithstanding anything to the contrary in the product supplement.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">4</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Terms of Your Notes</div>
    <div style="text-align: justify; margin-bottom: 12pt;">You should read this pricing supplement together with the prospectus, as supplemented by the product supplement MLN-EI-1 (the &#8220;product supplement&#8221;) and the underlier supplement (the &#8220;underlier
      supplement&#8221;), relating to our Senior Debt Securities, Series H, of which these Notes are a part. Capitalized terms used but not defined in this pricing supplement will have the meanings given to them in the product supplement. In the event of any
      conflict the following hierarchy will govern: first, this pricing supplement; second, the product supplement; third, the underlier supplement; and last, the prospectus. <font style="font-weight: bold; font-style: italic;">The Notes vary from the
        terms described in the product supplement in several important ways. You should read this pricing supplement carefully.</font></div>
    <div style="text-align: justify; margin-bottom: 12pt;">This pricing supplement, together with the documents listed below, contains the terms of the Notes and supersedes all prior or contemporaneous oral statements as well as any other written materials
      including preliminary or indicative pricing terms, correspondence, trade ideas, structures for implementation, sample structures, brochures or other educational materials of ours. You should carefully consider, among other things, the matters set
      forth in &#8220;Additional Risk Factors&#8221; herein, &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus, as the Notes involve risks not associated with conventional debt securities. We urge you to
      consult your investment, legal, tax, accounting and other advisors concerning an investment in the Notes. You may access these documents on the SEC website at www.sec.gov as follows (or if that address has changed, by reviewing our filings for the
      relevant date on the SEC website):</div>
    <table cellspacing="0" cellpadding="0" id="z5f5fdaa8eb9e44cbb3c079bc3423f955" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; font-size: 7pt;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Prospectus dated February 26, 2025:</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 0pt; margin-left: 18pt; margin-bottom: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm">http://www.sec.gov/Archives/edgar/data/947263/000119312525036639/d931193d424b5.htm</a></div>
    <table cellspacing="0" cellpadding="0" id="za555e28da6d44e118e301ede456b6035" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 7pt; font-style: normal; font-variant: normal; text-transform: none;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Underlier Supplement dated February 26, 2025:</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 0pt; margin-left: 18pt; margin-bottom: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006121/ef20044458_424b3.htm</a></div>
    <table cellspacing="0" cellpadding="0" id="z7115e3472508452aa6adbfc924f94005" class="DSPFListTable" style="font-family: Arial; font-size: 9pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 18pt; vertical-align: top; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-size: 7pt; font-style: normal; font-variant: normal; text-transform: none;">&#9632;</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div>Product Supplement MLN-EI-1 dated February 26, 2025:</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; text-indent: 0pt; margin-left: 18pt; margin-bottom: 10pt;"><a href="https://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm">http://www.sec.gov/Archives/edgar/data/947263/000114036125006123/ef20044459_424b3.htm</a></div>
    <div style="text-align: justify; margin-bottom: 12pt;">Our Central Index Key, or CIK, on the SEC website is 0000947263. As used in this pricing supplement, the &#8220;Bank,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refers to The Toronto-Dominion Bank and its subsidiaries.</div>
    <div style="text-align: justify;">
      <div>
        <div style="margin-bottom: 12pt;">We reserve the right to change the terms of, or reject any offer to purchase, the Notes prior to their issuance. In the event of any changes to the terms of the Notes, we will notify you and you will be asked to
          accept such changes in connection with your purchase. You may also choose to reject such changes, in which case we may reject your offer to purchase.</div>
      </div>
      <div>This amended and restated pricing supplement amends, restates and supersedes the pricing supplement related hereto dated October 16, 2025 in its entirety.</div>
      <div style="text-align: left;"> <br>
      </div>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">5</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Risk Factors</div>
    <div style="text-align: justify; margin-top: 6pt;">The Notes involve risks not associated with an investment in conventional debt securities. This section describes the most significant risks relating to the terms of the Notes. For additional
      information as to these and other risks, please see &#8220;Additional Risk Factors Specific to the Notes&#8221; in the product supplement and &#8220;Risk Factors&#8221; in the prospectus.</div>
    <div style="text-align: justify; margin-top: 6pt;">Investors should consult their investment, legal, tax, accounting and other advisors as to the risks concerning an investment in the Notes and the suitability of the Notes in light of their particular
      circumstances.</div>
    <div style="text-align: center; margin-top: 12pt; font-style: italic; font-weight: bold;">Risks Relating to Return Characteristics</div>
    <div style="margin-top: 6pt; font-weight: bold;">Your Investment in the Notes May Result in a Loss.</div>
    <div style="text-align: justify; margin-top: 6pt;">The Notes do not guarantee the return of the Principal Amount and investors may lose up to their entire investment in the Notes. Specifically, if the Final Value of any Reference Asset is less than its
      Barrier Value, investors will lose 1% of the Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Notes Do Not Pay Interest and Your Return on the Notes May Be Less Than the Return on a Conventional Debt Security of Comparable Maturity.</div>
    <div style="text-align: justify; margin-top: 6pt;">There will be no periodic interest payments on the Notes as there would be on a conventional fixed-rate or floating-rate debt security having a comparable maturity. The return that you will receive on
      the Notes, which could be negative, may be less than the return you could earn on other investments. Even if your return on the Notes is positive, your return may be less than the return you would earn if you bought a conventional, interest -bearing
      senior debt security of TD of comparable maturity. Your investment may not reflect the full opportunity cost to you when you take into account factors that affect the time value of money.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Payment at Maturity Is Not Linked to the Value of Any Reference Asset at Any Time Other than on the Final Valuation Date.</div>
    <div style="text-align: justify; margin-top: 6pt;">The Final Value of each Reference Asset will be based on its Closing Value on the Final Valuation Date. Therefore, if the Closing Value of any Reference Asset dropped precipitously on the Final
      Valuation Date, the Payment at Maturity for your Notes may be significantly less than it would have been had the Payment at Maturity been linked to the Closing Values of the Reference Assets prior to such drop. Although the actual Closing Values of
      the Reference Assets on the Maturity Date or at other times during the term of your Notes may be higher than their Closing Values on the Final Valuation Date, your return is based only on the Closing Value of the Least Performing Reference Asset on
      the Final Valuation Date.</div>
    <div style="text-align: center; margin-top: 12pt; font-style: italic; font-weight: bold;">Risks Relating to Characteristics of the Reference Assets</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">There Are Market Risks Associated With Each Reference Asset.</div>
    <div style="text-align: justify; margin-top: 6pt;">The value of each Reference Asset can rise or fall sharply due to factors specific to such Reference Asset, its Reference Asset Constituents and their issuers (the &#8220;Reference Asset Constituent
      Issuers&#8221;), such as stock price volatility, earnings, financial conditions, corporate, industry and regulatory developments, management changes and decisions and other events, as well as general market factors, such as general stock market volatility
      and levels, interest rates and economic and political conditions. You, as an investor in the Notes, should make your own investigation into the Reference Assets, the Reference Asset Constituents and the Reference Asset Constituent Issuers for your
      Notes. For additional information, see &#8220;Information Regarding the Reference Assets&#8221; in this pricing supplement.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Investors Are Exposed to the Market Risk of Each Reference Asset on the Final Valuation Date.</div>
    <div style="text-align: justify; margin-top: 6pt;">Your return on the Notes is not linked to a basket consisting of the Reference Assets. Rather, it will be contingent upon the performance of each Reference Asset. Unlike an instrument with a return
      linked to a basket of indices, common stocks or other underlying securities, in which risk is mitigated and diversified among all of the components of the basket, you will be exposed equally to the risks related to each Reference Asset on the Final
      Valuation Date. Poor performance by any Reference Asset over the term of the Notes will negatively affect your return and will not be offset or mitigated by a positive performance by any other Reference Asset. For instance, if the Final Value of any
      Reference Asset is less than its Barrier Value on its Final Valuation Date, you will receive a negative return equal to the Least Performing Percentage Change, even if the Percentage Change of another Reference Asset is positive or has not declined
      as much. Accordingly, your investment is subject to the market risk of each Reference Asset.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Because the Notes Are Linked to the Least Performing Reference Asset, You Are Exposed to a Greater Risk of Losing a Significant Portion or All of Your Initial Investment at Maturity
      Than if the Notes Were Linked to a Single Reference Asset or Fewer Reference Assets.</div>
    <div style="text-align: justify; margin-top: 6pt;">The risk that you will lose a significant portion or all of your initial investment in the Notes is greater if you invest in the Notes than the risk of investing in substantially similar securities
      that are linked to the performance of only one Reference Asset or fewer Reference Assets. With more Reference Assets, it is more likely that the Final Value of any Reference Asset will be less than its Barrier Value on the Final Valuation Date than
      if the Notes were linked to a single Reference Asset or fewer Reference Assets.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">6</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-top: 6pt;">In addition, the lower the correlation is between the performance of a pair of Reference Assets, the more likely it is that one of the Reference Assets will decline in value to a Final Value that is
      less than its Barrier Value on the Final Valuation Date. Although the correlation of the Reference Assets&#8217; performance may change over the term of the Notes, the economic terms of the Notes, including the Barrier Values and Leverage Factor, are
      determined, in part, based on the correlation of the Reference Assets&#8217; performance calculated using our internal models at the time when the terms of the Notes are finalized. All things being equal, a lower Barrier Value and a higher Leverage Factor
      are generally associated with lower correlation of the Reference Assets. Therefore, if the performance of a pair of Reference Assets is not correlated to each other or is negatively correlated, the risk that the Final Value of any Reference Asset
      will be less than its Barrier Value is even greater despite a lower Barrier Value. Therefore, it is more likely that you will lose a significant portion or all of your initial investment at maturity.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">We Have No Affiliation With Any Index Sponsor and Will Not Be Responsible for Any Actions Taken by Any Index Sponsor.</div>
    <div style="text-align: justify; margin-top: 6pt;">No index sponsor as specified under &#8220;Information Regarding the Reference Assets&#8221; (an &#8220;Index Sponsor&#8221;) is an affiliate of ours and no such entity will be involved in any offering of the Notes in any
      way. Consequently, we have no control of any actions of any Index Sponsor, including any actions of the type that could adversely affect the value of the applicable Reference Asset or any amounts payable on the Notes. No Index Sponsor has any
      obligation of any sort with respect to the Notes. Thus, no Index Sponsor has any obligation to take your interests into consideration for any reason, including in taking any actions that might affect the value of the Notes. None of our proceeds from
      any issuance of the Notes will be delivered to any Index Sponsor, except to the extent that we are required to pay an Index Sponsor licensing fees with respect to the applicable Reference Asset.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Changes that Affect the Reference Assets May Adversely Affect the Market Value of, and Return on, the Notes.</div>
    <div style="text-align: justify; margin-top: 6pt;">The policies of each Index Sponsor concerning the calculation of the applicable Reference Asset, additions, deletions or substitutions of the Reference Asset Constituents and the manner in which
      changes affecting those Reference Asset Constituents, such as stock dividends, reorganizations or mergers, may be reflected in the applicable Reference Asset and could adversely affect the market value of, and return on, the Notes. The market value
      of, and return on, the Notes could also be affected if an Index Sponsor changes these policies, for example, by changing the manner in which it calculates the applicable Reference Asset, or if an Index Sponsor discontinues or suspends calculation or
      publication of the applicable Reference Asset. If events such as these occur, the Calculation Agent may select a successor index or take other actions as discussed in the product supplement and, notwithstanding these adjustments, the market value of,
      and return on, the Notes may be adversely affected.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index Reflects Price Return, not Total Return.</div>
    <div style="text-align: justify; margin-top: 6pt;">The return on the Notes is based on the performance of the Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index, which reflects the changes in the
      market prices of its Reference Asset Constituents. The Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>, Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> and Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index is not a &#8220;total return&#8221; index or strategy, which, in addition to reflecting those price
      returns, would also reflect dividends paid on its Reference Asset Constituents. The return on the Notes will not include such a total return feature or dividend component.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Notes are Subject to Risks Associated with Small-Capitalization Companies.</div>
    <div style="text-align: justify; margin-top: 6pt;">The Notes are subject to risks associated with small-capitalization companies because the Reference Asset Constituents of the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index are considered small-capitalization
      companies. These companies often have greater stock price volatility, lower trading volume and less liquidity than large-capitalization companies and therefore such index may be more volatile than an index in which a greater percentage of its
      constituents are issued by large-capitalization companies. Stock prices of small-capitalization companies are also more vulnerable than those of large-capitalization companies to adverse business and economic developments, and the stocks of
      small-capitalization companies may be thinly traded. In addition, small-capitalization companies are typically less stable financially than large-capitalization companies and may depend on a small number of key personnel, making them more vulnerable
      to loss of personnel. Small-capitalization companies are often given less analyst coverage and may be in early, and less predictable, periods of their corporate existences. Such companies tend to have smaller revenues, less diverse product lines,
      smaller shares of their product or service markets, fewer financial resources and less competitive strengths than large-capitalization companies and are more susceptible to adverse developments related to their products.</div>
    <div style="text-align: center; margin-top: 12pt; font-style: italic; font-weight: bold;">Risks Relating to Estimated Value and Liquidity</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Less Than the Public Offering Price of Your Notes.</div>
    <div style="text-align: justify; margin-top: 6pt;">The estimated value of your Notes is less than the public offering price of your Notes. The difference between the public offering price of your Notes and the estimated value of the Notes reflects
      costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes. Because hedging our obligations entails risks and may be influenced by market forces beyond our control, this hedging
      may result in a profit that is more or less than expected, or a loss.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">7</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Based on Our Internal Funding Rate.</div>
    <div style="text-align: justify; margin-top: 6pt;">The estimated value of your Notes is determined by reference to our internal funding rate. The internal funding rate used in the determination of the estimated value of the Notes generally represents a
      discount from the credit spreads for our conventional, fixed-rate debt securities and the borrowing rate we would pay for our conventional, fixed-rate debt securities. This discount is based on, among other things, our view of the funding value of
      the Notes as well as the higher issuance, operational and ongoing liability management costs of the Notes in comparison to those costs for our conventional, fixed-rate debt, as well as estimated financing costs of any hedge positions, taking into
      account regulatory and internal requirements. If the interest rate implied by the credit spreads for our conventional, fixed-rate debt securities, or the borrowing rate we would pay for our conventional, fixed-rate debt securities were to be used, we
      would expect the economic terms of the Notes to be more favorable to you. Additionally, assuming all other economic terms are held constant, the use of an internal funding rate for the Notes is expected to increase the estimated value of the Notes at
      any time.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Estimated Value of the Notes Is Based on Our Internal Pricing Models, Which May Prove to Be Inaccurate and May Be Different From the Pricing Models of Other Financial
      Institutions.</div>
    <div style="text-align: justify; margin-top: 6pt;">The estimated value of your Notes is based on our internal pricing models when the terms of the Notes are set, which take into account a number of variables, such as our internal funding rate on the
      Pricing Date, and are based on a number of subjective assumptions, which are not evaluated or verified on an independent basis and may or may not materialize. Further, our pricing models may be different from other financial institutions&#8217; pricing
      models and the methodologies used by us to estimate the value of the Notes may not be consistent with those of other financial institutions that may be purchasers or sellers of Notes in the secondary market. As a result, the secondary market price of
      your Notes may be materially less than the estimated value of the Notes determined by reference to our internal pricing models. In addition, market conditions and other relevant factors in the future may change, and any assumptions may prove to be
      incorrect.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Estimated Value of Your Notes Is Not a Prediction of the Prices at Which You May Sell Your Notes in the Secondary Market, if Any, and Such Secondary Market Prices, if Any, Will
      Likely Be Less Than the Public Offering Price of Your Notes and May Be Less Than the Estimated Value of Your Notes.</div>
    <div style="text-align: justify; margin-top: 6pt;">The estimated value of the Notes is not a prediction of the prices at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market
      transactions (if they are willing to purchase, which they are not obligated to do). The price at which you may be able to sell your Notes in the secondary market at any time, if any, will be influenced by many factors that cannot be predicted, such
      as market conditions, and any bid and ask spread for similar sized trades, and may be substantially less than the estimated value of the Notes. Further, as secondary market prices of your Notes take into account the levels at which our debt
      securities trade in the secondary market, and do not take into account our various costs and expected profits associated with selling and structuring the Notes, as well as hedging our obligations under the Notes, secondary market prices of your Notes
      will likely be less than the public offering price of your Notes. As a result, the price at which the Agent, other affiliates of ours or third parties may be willing to purchase the Notes from you in secondary market transactions, if any, will likely
      be less than the price you paid for your Notes, and any sale prior to the Maturity Date could result in a substantial loss to you.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Temporary Price at Which the Agent May Initially Buy the Notes in the Secondary Market May Not Be Indicative of Future Prices of Your Notes.</div>
    <div style="text-align: justify; margin-top: 6pt;">
      <div style="margin-top: 6pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary market (if the Agent makes a market in the Notes, which it is
        not obligated to do) may exceed the estimated value of the Notes on the Pricing Date, as well as the secondary market value of the Notes, for a temporary period after the Issue Date of the Notes, as discussed further under &#8220;Additional Information
        Regarding the Estimated Value of the Notes.&#8221; The price at which the Agent may initially buy or sell the Notes in the secondary market may not be indicative of future prices of your Notes.</div>
    </div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Underwriting Discount, Offering Expenses and Certain Hedging Costs Are Likely to Adversely Affect Secondary Market Prices.</div>
    <div style="text-align: justify; margin-top: 6pt;">Assuming no changes in market conditions or any other relevant factors, the price, if any, at which you may be able to sell the Notes will likely be less than the public offering price. The public
      offering price includes, and any price quoted to you is likely to exclude, any underwriting discount paid in connection with the initial distribution, offering expenses as well as the cost of hedging our obligations under the Notes. In addition, any
      such price is also likely to reflect dealer discounts, mark-ups and other transaction costs, such as a discount to account for costs associated with establishing or unwinding any related hedge transaction.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">There May Not Be an Active Trading Market for the Notes &#8212; Sales in the Secondary Market May Result in Significant Losses.</div>
    <div style="text-align: justify; margin-top: 6pt;">There may be little or no secondary market for the Notes. The Notes will not be listed or displayed on any securities exchange or electronic communications network. The Agent or another of our
      affiliates may make a market for the Notes; however, it is not required to do so and may stop any market-making activities at any time. Even if a secondary market for the Notes develops, it may not provide significant liquidity or trade at prices
      advantageous to you. We expect that transaction costs in any secondary market would be high. As a result, the difference between bid and ask prices for your Notes in any secondary market could be substantial.</div>
    <div style="text-align: justify; margin-top: 6pt;">If you sell your Notes before the Maturity Date, you may have to do so at a substantial discount from the public offering price irrespective of the value of the then-current least performing Reference
      Asset, and as a result, you may suffer substantial losses.</div>
    <br>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">8</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-top: 6pt;">
      <div style="margin-top: 6pt; color: rgb(0, 0, 0); font-weight: bold;">If the Value of Any Reference Asset Changes, the Market Value of Your Notes May Not Change in the Same Manner.</div>
      <div style="margin-top: 6pt;">Your Notes may trade quite differently from the performance of any of the Reference Assets. Any payment on the Notes will be based solely on the Final Value of the Least Performing Reference Asset on
        the Final Valuation Date. Changes in the value of any Reference Asset may not result in a comparable change in the market value of your Notes. Even if the Closing Value of each Reference Asset remains greater than or equal to its Barrier Value or
        increases to greater than its Initial Value during the term of the Notes, the market value of your Notes may not increase by the same amount and could decline<font style="color: rgb(0, 0, 0);">.</font></div>
    </div>
    <div style="text-align: center; margin-top: 12pt; font-style: italic; font-weight: bold;">Risks Relating to Hedging Activities and Conflicts of Interest</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">There Are Potential Conflicts of Interest Between You and the Calculation Agent.</div>
    <div style="text-align: justify; margin-top: 6pt;">The Calculation Agent will, among other things, determine the Payment at Maturity on the Notes. We will serve as the Calculation Agent and may appoint a different Calculation Agent after the Issue Date
      without notice to you. The Calculation Agent will exercise its judgment when performing its functions and may have a conflict of interest if it needs to make certain decisions. For example, the Calculation Agent may have to determine whether a market
      disruption event affecting a Reference Asset has occurred, and make certain adjustments if certain events occur, which may, in turn, depend on the Calculation Agent&#8217;s judgment as to whether the event has materially interfered with our ability or the
      ability of one of our affiliates to unwind our hedge positions. Because this determination by the Calculation Agent may affect the amount payable on the Notes, the Calculation Agent may have a conflict of interest if it needs to make a determination
      of this kind. For additional information on the Calculation Agent&#8217;s role, see &#8220;General Terms of the Notes &#8212; Role of Calculation Agent&#8221; in the product supplement.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The Final Valuation Date and the Maturity Date Are Subject to Market Disruption Events and Postponements.</div>
    <div style="text-align: justify; margin-top: 6pt;">The Final Valuation Date, and therefore the Maturity Date, are subject to postponement due to the occurrence of one or more market disruption events. For a description of what constitutes a market
      disruption event as well as the consequences of a market disruption event, see &#8220;General Terms of the Notes &#8212; Market Disruption Events&#8221; in the product supplement. A market disruption event for a particular Reference Asset will not constitute a market
      disruption event for any other Reference Asset.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Trading and Business Activities by TD or Its Affiliates May Adversely Affect the Market Value Of, and Any Amounts Payable On, the Notes.</div>
    <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0);">We, the Agent and/or our other affiliates may hedge our obligations under the Notes by purchasing securities, futures, options or other derivative instruments with returns linked
      or related to changes in the value of a Reference Asset or one or more Reference Asset Constituents, and we may adjust these hedges by, among other things, purchasing or selling at any time any of the foregoing assets. It is possible that we or one
      or more of our affiliates could receive substantial returns from these hedging activities while the market value of the Notes declines. We or one or more of our affiliates may also issue or underwrite other securities or financial or derivative
      instruments with returns linked or related to changes in a Reference Asset or one or more Reference Asset Constituents.</div>
    <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0);">These trading activities may present a conflict between the holders&#8217; interest in the Notes and the interests we and our affiliates will have in our or their proprietary accounts,
      in facilitating transactions, including options and other derivatives transactions, for our or their customers&#8217; accounts and in accounts under our or their management. These trading activities could be adverse to the interests of the holders of the
      Notes.</div>
    <div style="text-align: justify; margin-top: 6pt; color: rgb(0, 0, 0);">We, the Agent and/or our other affiliates may, at present or in the future, engage in business with one or more Reference Asset Constituent Issuers, including making loans to or
      providing advisory services to those companies. These services could include investment banking and merger and acquisition advisory services. These business activities may present a conflict between our, the Agent&#8217;s and/or our other affiliates&#8217;
      obligations, and your interests as a holder of the Notes. Moreover, we, the Agent and/or our other affiliates may have published, and in the future expect to publish, research reports with respect to a Reference Asset or one or more Reference Asset
      Constituents. This research is modified from time to time without notice and may express opinions or provide recommendations that are inconsistent with purchasing or holding the Notes. Any of these activities by us and/or our other affiliates may
      affect the value of a Reference Asset and, therefore, the market value of, and return on, the Notes.</div>
    <div style="text-align: center; margin-top: 12pt; font-style: italic; font-weight: bold;">Risks Relating to General Credit Characteristics</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Investors Are Subject to TD&#8217;s Credit Risk, and TD&#8217;s Credit Ratings and Credit Spreads May Adversely Affect the Market Value of the Notes.</div>
    <div style="text-align: justify; margin-top: 6pt;">Although the return on the Notes will be based on the performance of the Least Performing Reference Asset, the payment of any amount due on the Notes is subject to TD&#8217;s credit risk. The Notes are TD&#8217;s
      senior unsecured debt obligations. Investors are dependent on TD&#8217;s ability to pay all amounts due on the Notes and, therefore, investors are subject to the credit risk of TD and to changes in the market&#8217;s view of TD&#8217;s creditworthiness. Any decrease
      in TD&#8217;s credit ratings or increase in the credit spreads charged by the market for taking TD&#8217;s credit risk is likely to adversely affect the market value of the Notes. If TD becomes unable to meet its financial obligations as they become due,
      investors may not receive any amounts due under the terms of the Notes.</div>
    <br>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">9</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-top: 6pt;">
      <div style="text-align: center; margin-top: 12pt; font-style: italic; font-weight: bold;">Risks Relating to Canadian and U.S. Federal Income Taxation</div>
      <div style="margin: 6pt 0px; font-weight: bold;">Significant Aspects of the Tax Treatment of the Notes Are Uncertain.</div>
      <div>The U.S. tax treatment of the Notes is uncertain. Please read carefully the section entitled &#8220;Material U.S. Federal Income Tax Consequences&#8221; herein and in the product supplement. You should consult your tax advisor
        as to the tax consequences of your investment in the Notes.<br>
      </div>
    </div>
    <div style="text-align: justify; margin-top: 6pt;">For a discussion of the Canadian federal income tax consequences of investing in the Notes, please see the discussion in the prospectus under &#8220;Tax Consequences &#8212; Canadian Taxation&#8221; and in the product
      supplement under &#8220;Supplemental Discussion of Canadian Tax Consequences&#8221; and the further discussion herein under &#8220;Summary&#8221;. If you are not a Non-resident Holder (as that term is defined in the prospectus) for Canadian federal income tax purposes or if
      you acquire the Notes in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the Notes and receiving the payments that might be due under the Notes.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">10</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 3pt; color: rgb(0, 176, 80); font-size: 16pt;">Hypothetical Returns</div>
    <div style="text-align: justify; margin-top: 3pt;">The examples and table set out below are included for illustration purposes only and are hypothetical examples only: amounts below may have been rounded for ease of analysis. The hypothetical
      Percentage Changes of the Reference Assets used to illustrate the calculation of the Payment at Maturity are not estimates or forecasts of the Initial Values, the Final Values or the values of the Reference Assets on any Trading Day prior to the
      Maturity Date. All examples reflect Barrier Values equal to 70.00% of the Initial Values, the Leverage Factor of 168.00%, that a holder purchased Notes with an aggregate Principal Amount of $1,000 and that no market disruption event occurs on the
      Final Valuation Date. The actual terms of the Notes are set forth elsewhere in this pricing supplement.</div>
    <br>
    <table cellspacing="0" cellpadding="0" border="0" id="z71da8554f5e046b9bacc3d43646b522b" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 12%; vertical-align: top;">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Example 1 &#8212;</div>
          </td>
          <td style="vertical-align: top;" colspan="2">
            <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Calculation of the Payment at Maturity where the Final Value of each Reference Asset is greater than its Initial Value.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 18%; vertical-align: top;">
            <div style="margin-bottom: 3pt;">Least Performing Percentage Change:</div>
          </td>
          <td style="width: 70%; vertical-align: top;">
            <div style="text-align: justify; margin-bottom: 6pt;">5.00%</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 18%; vertical-align: top;">
            <div style="text-align: justify; margin-bottom: 6pt;">Payment at Maturity:</div>
          </td>
          <td style="width: 70%; vertical-align: top;">
            <div style="text-align: justify; margin-bottom: 6pt;">= $1,000.00 + ($1,000.00 &#215; 5.00% &#215; 168.00%)</div>
            <div style="text-align: justify; margin-bottom: 6pt;">= $1,000.00 + $84.00</div>
            <div style="text-align: justify; margin-bottom: 6pt;">= $1,084.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top;" colspan="2">
            <div style="margin: 0px 0px 15pt; text-align: justify;">On a $1,000.00 investment, a Least Performing Percentage Change of 5.00% results in a Payment at Maturity of $1,084.00, a return of 8.40% on the Notes.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zfececd7efb5e4d0595f0a4afc526892a" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 12%; vertical-align: top;">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Example 2 &#8212;</div>
          </td>
          <td style="vertical-align: top;" colspan="2">
            <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Calculation of the Payment at Maturity where the Final Value of any Reference Asset is less than or equal to its Initial Value, but the Final Value of each Reference Asset
              is greater than or equal to its Barrier Value.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 18%; vertical-align: top;">
            <div style="margin-bottom: 6pt;">Least Performing Percentage Change:</div>
          </td>
          <td style="width: 70%; vertical-align: top;">
            <div style="text-align: justify; margin-bottom: 6pt;">-5.00%</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 18%; vertical-align: top;">
            <div style="text-align: justify; margin-bottom: 6pt;">Payment at Maturity:</div>
          </td>
          <td style="width: 70%; vertical-align: top;">
            <div style="text-align: justify; margin-bottom: 6pt;">At maturity, if the Final Value of any Reference Asset is less than or equal to its Initial Value but the Final Value of each Reference Asset is greater than or equal to its Barrier Value,
              then the Payment at Maturity will equal the Principal Amount.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top;" colspan="2">
            <div style="margin: 0px 0px 15pt; text-align: justify;">On a $1,000.00 investment, a Least Performing Percentage Change of -5.00% results in a Payment at Maturity of<font style="font-size: 12pt;">&#160;</font>$1,000.00, a return of 0.00% on the
              Notes.</div>
          </td>
        </tr>

    </table>
    <table cellspacing="0" cellpadding="0" id="zcc0e6ada2f074d0cb2c02cbd54279113" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 12%; vertical-align: top;">
            <div style="text-align: justify; margin-bottom: 6pt; font-weight: bold;">Example 3 &#8212;</div>
          </td>
          <td colspan="2" rowspan="1" style="vertical-align: top;">
            <div style="text-align: justify; margin-bottom: 3pt; font-weight: bold;">Calculation of the Payment at Maturity where the Final Value of any Reference Asset is less than its Barrier Value.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 18%; vertical-align: top;">
            <div style="margin-bottom: 6pt;">Least Performing Percentage Change:</div>
          </td>
          <td style="width: 70%; vertical-align: top;">
            <div style="text-align: justify; margin-bottom: 6pt;">-60.00%</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="width: 18%; vertical-align: top;">
            <div style="text-align: justify; margin-bottom: 6pt;">Payment at Maturity:</div>
          </td>
          <td style="width: 70%; vertical-align: top;">
            <div style="text-align: justify; margin-bottom: 3pt;">= $1,000.00 + ($1,000.00 &#215; -60.00%)</div>
            <div style="text-align: justify; margin-bottom: 3pt;">= $1,000.00 - $600.00</div>
            <div style="text-align: justify; margin-bottom: 3pt;">= $400.00</div>
          </td>
        </tr>
        <tr>
          <td style="width: 12%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top;" colspan="2">
            <div style="text-align: justify;">On a $1,000.00 investment, a Least Performing Percentage Change of -60.00% results in a Payment at Maturity of $400.00, a loss of 60.00% on the Notes.</div>
            <div>&#160;</div>
            <div style="text-align: justify; font-weight: bold;">In this scenario, investors will suffer a percentage loss on their initial investment that is equal to the Least Performing Percentage Change. Specifically, investors will lose 1% of the
              Principal Amount of the Notes for each 1% that the Final Value of the Least Performing Reference Asset is less than its Initial Value, and may lose the entire Principal Amount. Any payment on the Notes is subject to our credit risk.</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">11</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-top: 12pt;">The following table shows the hypothetical return profile for the Notes on the Maturity Date, based on the hypothetical terms set forth above and assuming that the investor purchased the Notes at the
      public offering price and held the Notes until the Maturity Date. The hypothetical returns on the Notes illustrated in the following table are not estimates or forecasts of the Percentage Change of the Least Performing Reference Asset or the return
      or loss on the Notes. Neither TD nor the Agent is predicting or guaranteeing any gain or particular return on the Notes.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" align="center" id="za5049f58f5334142aa7d93fc660945d6" style="border-collapse: collapse; width: 60%; color: #000000; font-family: Arial; font-size: 9pt; text-align: left;">

        <tr>
          <td style="width: 20%; vertical-align: middle; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="margin: 5pt 0px 0px; font-weight: bold; text-align: center;">Hypothetical Least</div>
            <div style="text-align: center; font-weight: bold;">Performing</div>
            <div style="margin: 0px 0px 5pt; font-weight: bold; text-align: center;">Percentage Change</div>
          </td>
          <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="margin: 5pt 0px 0px; font-weight: bold; text-align: center;">Hypothetical Payment</div>
            <div style="margin: 0px 0px 5pt; font-weight: bold; text-align: center;">at Maturity ($)</div>
          </td>
          <td style="width: 20%; vertical-align: middle; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="margin: 5pt 0px 0px; font-weight: bold; text-align: center;">Hypothetical Return</div>
            <div style="margin: 0px 0px 5pt; font-weight: bold; text-align: center;">on Notes (%)</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">40.00%</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$1,672.00</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">67.20%</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">30.00%</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$1,504.00</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">50.40%</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">20.00%</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$1,336.00</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">33.60%</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">10.00%</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$1,168.00</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">16.80%</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">5.00%</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$1,084.00</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">8.40%</div>
          </td>
        </tr>
        <tr>
          <td style="background-color: #EAF1DD; border-bottom: 1px solid #000000; border-left: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; white-space: nowrap; width: 20%;">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">0.00%</div>
          </td>
          <td style="background-color: #EAF1DD; border-bottom: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; white-space: nowrap; width: 20%;">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$1,000.00</div>
          </td>
          <td style="background-color: #EAF1DD; border-bottom: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; white-space: nowrap; width: 20%;">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">0.00%</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-10.00%</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$1,000.00</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">0.00%</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-20.00%</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$1,000.00</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">0.00%</div>
          </td>
        </tr>
        <tr>
          <td style="background-color: rgb(234, 241, 221); border-bottom: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0); vertical-align: top; white-space: nowrap; width: 20%; border-left: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-30.00%</div>
          </td>
          <td style="background-color: #EAF1DD; border-bottom: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; white-space: nowrap; width: 20%;">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$1,000.00</div>
          </td>
          <td style="background-color: #EAF1DD; border-bottom: 1px solid #000000; border-right: 1px solid #000000; vertical-align: top; white-space: nowrap; width: 20%;">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">0.00%</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-40.00%</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$600.00</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-40.00%</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-50.00%</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$500.00</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-50.00%</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-75.00%</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$250.00</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-75.00%</div>
          </td>
        </tr>
        <tr>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-100.00%</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">$0.00</div>
          </td>
          <td nowrap="nowrap" style="width: 20%; vertical-align: top; border-right: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: center; margin-top: 1pt; margin-bottom: 1pt;">-100.00%</div>
          </td>
        </tr>

    </table>
    <div> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">12</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Information Regarding the Reference Assets</div>
    <div style="text-align: justify; margin-top: 6pt;">All disclosures contained in this document regarding the Reference Assets, including, without limitation, their make-up, methods of calculation, and changes in any Reference Asset Constituents, have
      been derived from publicly available sources. We have not undertaken an independent review or due diligence of any publicly available information with respect to any Reference Asset. The information reflects the policies of, and is subject to change
      by, the Index Sponsors. Each Index Sponsor, owns the copyright and all other rights to the relevant Reference Asset, has no obligation to continue to publish, and may discontinue publication of, the relevant Reference Asset. None of the websites
      referenced in the Reference Asset descriptions below, or any materials included in those websites, are incorporated by reference into this document or any document incorporated herein by reference.</div>
    <div style="text-align: justify; margin-top: 6pt;">The graphs below set forth the information relating to the historical performance of each Reference Asset. The graphs below show the daily historical Closing Values of each Reference Asset for the
      periods specified. We obtained the information regarding the historical performance of each Reference Asset in the graphs below from Bloomberg.</div>
    <div style="margin: 6pt 0px; text-align: justify;">We have not independently verified the accuracy or completeness of the information obtained from Bloomberg. The historical performance of each Reference Asset should not be taken as an indication of
      its future performance, and no assurance can be given as to the Final Value of any Reference Asset. We cannot give you any assurance that the performance of the Reference Assets will result in a positive return on your initial investment.</div>
    <table cellspacing="0" cellpadding="0" border="0" id="z6625b31c45a7456fb6546194f685d5bd" style="border-collapse: collapse; width: 5%; color: rgb(0, 0, 0); font-family: Arial; font-size: 9pt; text-align: left;">

        <tr>
          <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="font-weight: bold; text-align: justify;">Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
          </td>
        </tr>

    </table>
    <div style="margin: 6pt 0px; text-align: justify;">We have derived all information regarding the Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (&#8220;INDU&#8221;) contained in this document, including, without limitation, its make-up, method of calculation and changes
      in its components, from publicly available information. Such information reflects the policies of, and is subject to change by S&amp;P Dow Jones Indices LLC (its &#8220;Index Sponsor&#8221; or &#8220;S&amp;P Dow Jones&#8221;).</div>
    <div style="text-align: justify; margin-bottom: 6pt;">INDU is published by S&amp;P Dow Jones, but S&amp;P Dow Jones has no obligation to continue to publish INDU, and may discontinue publication of INDU at any time. INDU is determined, comprised and
      calculated by S&amp;P Dow Jones without regard to this instrument.</div>
    <div style="text-align: justify; margin-bottom: 6pt;">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8212; The Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;&#8221;,</sup> INDU is a price-weighted index composed of 30 U.S. blue-chip companies
      selected at the discretion of the Averages Committee, which is comprised of three representatives of S&amp;P Dow Jones and two representatives of The Wall Street Journal. While INDU component selection is not governed by quantitative rules, the
      Averages Committee selects the INDU components based on the company&#8217;s reputation, growth and interest to investors. Maintaining adequate sector representation is also a consideration in the selection process. INDU covers all industries with the
      exception of transportation and utilities. The Averages Committee may revise index policy covering rules for selecting companies, treatment of dividends, share counts or other matters.</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; font-weight: bold;">Historical Information</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 10pt;">The graph below illustrates the performance of INDU from October 16, 2015 through October 16, 2025. The dotted line represents its Barrier Value of 32,166.568, which is equal to
      70.00% of its Initial Value.</div>
    <div style="text-align: center; margin-top: 6pt; font-size: 12pt; font-weight: bold;">Dow Jones Industrial Average<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (INDU)</div>
    <div style="margin: 0px 0px 10pt; text-align: center;"><img src="image2.jpg"></div>
    <div style="text-align: center; font-style: italic; font-weight: bold;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
    <div style="text-align: center; font-style: italic; font-weight: bold;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">13</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z754d0328224a494492fd5e574075743d" style="font-family: Arial; font-size: 9pt; width: 5%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: justify; font-weight: bold;">Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup></div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(0, 0, 0);">We have derived all information regarding the Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (&#8220;NDX&#8221;) contained in this document, including, without limitation, its make-up,
      method of calculation and changes in its components, from publicly available information. Such information reflects the policies of, and is subject to change by Nasdaq, Inc. and its affiliates (collectively, &#8220;Nasdaq&#8221;) (its &#8220;Index Sponsor&#8221; or
      &#8220;Nasdaq&#8221;).</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(0, 0, 0);">NDX is published by Nasdaq, but Nasdaq has no obligation to continue to publish NDX, and may discontinue publication of NDX at any time. NDX is determined,
      comprised and calculated by Nasdaq without regard to this instrument.</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(0, 0, 0);">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8211; Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup>&#8221;, NDX includes 100 of the largest domestic and
      international non-financial securities listed on the Nasdaq Stock Market<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> based on market capitalization. NDX includes companies across major industry groups including computer hardware and software, telecommunications, retail and
      wholesale trade, and biotechnology, but does not contain securities of financial companies, including investment companies.</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(0, 0, 0);">NDX is calculated under a modified capitalization-weighted methodology. The methodology is expected to retain in general the economic attributes of
      capitalization-weighting while providing enhanced diversification. To accomplish this, Nasdaq will review the composition of NDX on a quarterly basis and adjust the weightings of components using a proprietary algorithm, if certain pre-established
      weight distribution requirements are not met.</div>
    <div style="margin-bottom: 10pt; font-weight: bold;">Historical Information</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 10pt;">The graph below illustrates the performance of NDX from October 16, 2015 through October 16, 2025. The dotted line represents its Barrier Value of 17,260.068, which is equal to
      70.00% of its Initial Value.</div>
    <div style="text-align: center; margin-top: 6pt; font-size: 12pt; font-weight: bold;">Nasdaq-100 Index<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> (NDX)</div>
    <div style="margin: 0px 0px 8pt; text-align: center;"><img src="image1.jpg"></div>
    <div style="text-align: center; font-size: 8pt; font-style: italic; font-weight: bold;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
    <div style="text-align: center; font-size: 8pt; font-style: italic; font-weight: bold;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">14</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z5f89445529db446fbf86d78967ff3a71" style="font-family: Arial; font-size: 9pt; width: 5%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

        <tr>
          <td nowrap="nowrap" style="width: 5%; vertical-align: top; border-bottom: 1px solid rgb(0, 0, 0);">
            <div style="text-align: justify; font-weight: bold;">Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index</div>
          </td>
        </tr>

    </table>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(0, 0, 0);">We have derived all information regarding the Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (&#8220;RTY&#8221;) contained in this document, including, without limitation, its make-up,
      method of calculation and changes in its components, from publicly available information. Such information reflects the policies of, and is subject to change by the Frank Russell Company (the &#8220;Index Sponsor&#8221; or &#8220;FTSE Russell&#8221;).</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(0, 0, 0);">RTY is published by FTSE Russell, but FTSE Russell has no obligation to continue to publish RTY, and may discontinue publication of RTY at any time. RTY is
      determined, comprised and calculated by FTSE Russell without regard to this instrument.</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt; color: rgb(0, 0, 0);">As discussed more fully in the underlier supplement under the heading &#8220;Indices &#8211; The Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index,&#8221; RTY measures the composite price
      performance of the smallest 2,000 companies included in the Russell 3000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index. The Russell 3000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index is composed of the 3,000 largest United States companies by market capitalization and represents approximately 98% of the
      market capitalization of the United States equity market. Select information regarding top constituents and industry and/or sector weightings may be made available by the Index Sponsor on its website. RTY&#8217;s value is calculated by adding the market
      values of the underlying constituents and then dividing the derived total market capitalization by the &#8220;adjusted&#8221; capitalization of RTY on the base date of December 31, 1986.</div>
    <div style="margin-bottom: 10pt; font-weight: bold;">Historical Information</div>
    <div style="text-align: justify; margin-top: 6pt; margin-bottom: 10pt;">The graph below illustrates the performance of RTY from October 16, 2015 through October 16, 2025. The dotted line represents its Barrier Value of 1,726.9105, which is equal to
      70.00% of its Initial Value.</div>
    <div style="text-align: center; margin-top: 6pt; font-size: 12pt; font-weight: bold;">Russell 2000<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">&#174;</sup> Index (RTY)</div>
    <div style="margin: 0px 0px 8pt; text-align: center;"><img src="image3.jpg"></div>
    <div style="text-align: center; font-size: 8pt; font-style: italic; font-weight: bold;">PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.</div>
    <div style="text-align: center; font-size: 8pt; font-style: italic; font-weight: bold;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">15</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 12pt; color: rgb(0, 176, 80); font-size: 16pt;">Material U.S. Federal Income Tax Consequences</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">The U.S. federal income tax consequences of your investment in the Notes are uncertain. No statutory, regulatory, judicial or administrative authority directly discusses how the
      Notes should be treated for U.S. federal income tax purposes. Some of these tax consequences are summarized below, but we urge you to read the more detailed discussion under &#8220;Material U.S. Federal Income Tax Consequences&#8221; in the product supplement
      and discuss the tax consequences of your particular situation with your tax advisor. This discussion is based upon the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;), final, temporary and proposed U.S. Department of the Treasury (the
      &#8220;Treasury&#8221;) regulations, rulings and decisions, in each case, as available and in effect as of the date hereof, all of which are subject to change, possibly with retroactive effect. Tax consequences under state, local and non-U.S. laws are not
      addressed herein. No ruling from the U.S. Internal Revenue Service (the &#8220;IRS&#8221;) has been sought as to the U.S. federal income tax consequences of your investment in the Notes, and the following discussion is not binding on the IRS.</div>
    <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">U.S. Tax Treatment.</font><font style="font-weight: bold;">&#160;</font>Pursuant to the terms of the Notes, TD and you agree, in the absence of a statutory or regulatory
      change or an administrative determination or judicial ruling to the contrary, to characterize your Notes as prepaid derivative contracts with respect to the Reference Assets. If your Notes are so treated, you should generally recognize gain or loss
      upon the taxable disposition (including cash settlement) of your Notes in an amount equal to the difference between the amount you receive at such time and the amount you paid for your Notes. Such gain or loss should generally be long-term capital
      gain or loss if you have held your Notes for more than one year (otherwise such gain or loss should be short-term capital gain or loss if held for one year or less). The deductibility of capital losses is subject to limitations.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Based on certain factual representations received from us, our special U.S. tax counsel, Fried, Frank, Harris, Shriver &amp; Jacobson LLP, is of the opinion that it would be
      reasonable to treat your Notes in the manner described above. However, because there is no authority that specifically addresses the tax treatment of the Notes, it is possible that your Notes could alternatively be treated for tax purposes as a
      single contingent payment debt instrument, or pursuant to some other characterization, such that the timing and character of your income from the Notes could differ materially and adversely from the treatment described above, as described further
      under &#8220;Material U.S. Federal Income Tax Consequences &#8212; Alternative Treatments&#8221; in the product supplement.</div>
    <div style="text-align: justify; margin-top: 6pt;">Except to the extent otherwise required by law, TD intends to treat your Notes for U.S. federal income tax purposes in accordance with the treatment described above and under &#8220;Material U.S. Federal
      Income Tax Consequences&#8221; of the product supplement, unless and until such time as the Treasury and the IRS determine that some other treatment is more appropriate.</div>
    <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Section 1297</font>. We will not attempt to ascertain whether any Reference Asset Constituent Issuer would be treated as a passive foreign investment company (&#8220;PFIC&#8221;)
      within the meaning of Section 1297 of the Code. If any such entity were so treated, certain adverse U.S. federal income tax consequences might apply upon the taxable disposition of a Note. You should refer to information filed with the SEC or the
      equivalent governmental authority by such entities and consult your tax advisors regarding the possible consequences to you if any such entity is or becomes a PFIC.</div>
    <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Notice 2008-2. </font>In 2007, the IRS released a notice that may affect the taxation of holders of the Notes. According to Notice 2008-2, the IRS and the Treasury
      are considering whether a holder of an instrument such as the Notes should be required to accrue ordinary income on a current basis. It is not possible to determine what guidance they will ultimately issue, if any. It is possible, however, that under
      such guidance, holders of the Notes will ultimately be required to accrue income currently and this could be applied on a retroactive basis. According to the Notice, the IRS and the Treasury are also considering other relevant issues, including
      whether additional gain or loss from such instruments should be treated as ordinary or capital, whether non-U.S. holders of such instruments should be subject to withholding tax on any deemed income accruals, and whether the special &#8220;constructive
      ownership rules&#8221; of Section 1260 of the Code should be applied to such instruments. Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the significance, and the potential impact, of the above considerations on their
      investments in the Notes.</div>
    <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Medicare Tax on Net Investment Income</font>. U.S. holders that are individuals, estates or certain trusts are subject to an additional 3.8% tax on all or a portion of
      their &#8220;net investment income&#8221; or &#8220;undistributed net investment income&#8221; in the case of an estate or trust, which may include any income or gain realized with respect to the Notes, to the extent of their net investment income or undistributed net
      investment income (as the case may be) that, when added to their other modified adjusted gross income, exceeds $200,000 for an unmarried individual, $250,000 for a married taxpayer filing a joint return (or a surviving spouse), $125,000 for a married
      individual filing a separate return or the dollar amount at which the highest tax bracket begins for an estate or trust. The 3.8% Medicare tax is determined in a different manner than the regular income tax. U.S. holders should consult their tax
      advisors as to the consequences of the 3.8% Medicare tax.</div>
    <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Specified Foreign Financial Assets. </font>Certain<font style="font-style: italic;">&#160;</font>U.S. holders that own &#8220;specified foreign financial assets&#8221; in excess of an
      applicable threshold may be subject to reporting obligations with respect to such assets with their tax returns, especially if such assets are held outside the custody of a U.S. financial institution. U.S. holders are urged to consult their tax
      advisors as to the application of this legislation to their ownership of the Notes.</div>
    <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Backup Withholding and Information Reporting. </font>The proceeds received from a taxable disposition of the Notes will be subject to information reporting unless you
      are an &#8220;exempt recipient&#8221; and may also be subject to backup withholding at the rate specified in the Code if you fail to provide certain identifying information (such as an accurate taxpayer number, if you are a U.S. holder) or meet certain other
      conditions.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">16</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Non-U.S. Holders.</font> If you are a non-U.S. holder, subject to Section 871(m) of the Code and FATCA, as discussed below, you should generally not be subject to U.S.
      withholding tax with respect to payments on your Notes or to generally applicable information reporting and backup withholding requirements with respect to payments on your Notes if you comply with certain certification and identification
      requirements as to your non-U.S. status including providing us (and/or the applicable withholding agent) a properly executed and fully completed applicable IRS Form W-8. Subject to Section 897 of the Code and Section 871(m) of the Code, as discussed
      below, gain realized from the taxable disposition of the Notes generally should not be subject to U.S. tax unless (i) such gain is effectively connected with a trade or business conducted by you in the U.S., (ii) you are a non-resident alien
      individual and are present in the U.S. for 183 days or more during the taxable year of such taxable disposition and certain other conditions are satisfied or (iii) you have certain other present or former connections with the U.S.</div>
    <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Section 897.</font> We will not attempt to ascertain whether any Reference Asset Constituent Issuer would be treated as a &#8220;United States real property holding
      corporation&#8221; (a &#8220;USRPHC&#8221;) within the meaning of Section 897 of the Code. We also have not attempted to determine whether the Notes should be treated as &#8220;United States real property interests&#8221; (&#8220;USRPI&#8221;) as defined in Section 897 of the Code. If any
      such entity and the Notes were so treated, certain adverse U.S. federal income tax consequences could possibly apply, including subjecting any gain to a non-U.S. holder in respect of a Note upon a taxable disposition of the Note to U.S. federal
      income tax on a net basis, and the proceeds from such a taxable disposition to a 15% withholding tax. Non-U.S. holders should consult their tax advisors regarding the potential treatment of any such entity as a USRPHC and the Notes as USRPI.</div>
    <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Section 871(m).</font> A 30% withholding tax (which may be reduced by an applicable income tax treaty) is imposed under Section 871(m) of the Code on certain &#8220;dividend
      equivalents&#8221; paid or deemed paid to a non-U.S. holder with respect to a &#8220;specified equity-linked instrument&#8221; that references one or more dividend-paying U.S. equity securities or indices containing U.S. equity securities. The withholding tax can
      apply even if the instrument does not provide for payments that reference dividends. Treasury regulations provide that the withholding tax applies to all dividend equivalents paid or deemed paid on specified equity-linked instruments that have a
      delta of one (&#8220;delta-one specified equity-linked instruments&#8221;) issued after 2016 and to all dividend equivalents paid or deemed paid on all other specified equity-linked instruments issued after 2017. However, the IRS has issued guidance that states
      that the Treasury and the IRS intend to amend the effective dates of the Treasury regulations to provide that withholding on dividend equivalents paid or deemed paid will not apply to specified equity-linked instruments that are not delta-one
      specified equity-linked instruments and are issued before January 1, 2027.</div>
    <div style="text-align: justify; margin-top: 6pt;">Based on the nature of the Reference Assets and our determination that the Notes are not &#8220;delta-one&#8221; with respect to the Reference Assets or any Reference Asset Constituent, our special U.S. tax
      counsel is of the opinion that the Notes should not be delta-one specified equity-linked instruments and thus should not be subject to withholding on dividend equivalents. Our determination is not binding on the IRS, and the IRS may disagree with
      this determination. Furthermore, the application of Section 871(m) of the Code will depend on our determinations on the date the terms of the Notes are set. If withholding is required, we will not make payments of any additional amounts.</div>
    <div style="text-align: justify; margin-top: 6pt;">Nevertheless, after the date the terms are set, it is possible that your Notes could be deemed to be reissued for tax purposes upon the occurrence of certain events affecting any Reference Asset, any
      Reference Asset Constituent or your Notes, and following such occurrence your Notes could be treated as delta-one specified equity-linked instruments that are subject to withholding on dividend equivalents. It is also possible that withholding tax or
      other tax under Section 871(m) of the Code could apply to the Notes under these rules if you enter, or have entered, into certain other transactions in respect of any Reference Asset, any Reference Asset Constituent or the Notes. If you enter, or
      have entered, into other transactions in respect of any Reference Asset, any Reference Asset Constituent or the Notes, you should consult your tax advisor regarding the application of Section 871(m) of the Code to your Notes in the context of your
      other transactions.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Because of the uncertainty regarding the application of the 30% withholding tax on dividend equivalents to the Notes, you are urged to consult your tax advisor regarding the
      potential application of Section 871(m) of the Code and the 30% withholding tax to an investment in the Notes.</div>
    <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">U.S. Federal Estate Tax Treatment of Non-U.S. Holders. </font>A Note may be subject to U.S. federal estate tax if an individual non-U.S. holder holds the Note at the
      time of his or her death. The gross estate of a non-U.S. holder domiciled outside the U.S. includes only property situated in the U.S. Individual non-U.S. holders should consult their tax advisors regarding the U.S. federal estate tax consequences of
      holding the Notes at death.</div>
    <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Foreign Account Tax Compliance Act. </font>The Foreign Account Tax Compliance Act (&#8220;FATCA&#8221;) was enacted on March 18, 2010, and imposes a 30% U.S. withholding tax on
      &#8220;withholdable payments&#8221; (i.e., certain U.S.-source payments, including interest (and original issue discount), dividends, other fixed or determinable annual or periodical income, and the gross proceeds from a disposition of property of a type that
      can produce U.S.-source interest or dividends) and &#8220;passthru payments&#8221; (i.e., certain payments attributable to withholdable payments) made to certain foreign financial institutions (and certain of their affiliates) unless the payee foreign financial
      institution agrees (or is required), among other things, to disclose the identity of any U.S. individual with an account at the institution (or the relevant affiliate) and to annually report certain information about such account. FATCA also requires
      withholding agents making withholdable payments to certain foreign entities that do not disclose the name, address, and taxpayer identification number of any substantial U.S. owners (or do not certify that they do not have any substantial U.S.
      owners) to withhold tax at a rate of 30%. Under certain circumstances, a holder may be eligible for refunds or credits of such taxes.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">17</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-top: 6pt;">Pursuant to final and temporary Treasury regulations and other IRS guidance, the withholding and reporting requirements under FATCA will generally apply to certain &#8220;withholdable payments&#8221;, will not
      apply to gross proceeds on a sale or disposition, and will apply to certain foreign passthru payments only to the extent that such payments are made after the date that is two years after final regulations defining the term &#8220;foreign passthru payment&#8221;
      are published. If withholding is required, we (or the applicable paying agent) will not be required to pay additional amounts with respect to the amounts so withheld. Foreign financial institutions and non-financial foreign entities located in
      jurisdictions that have an intergovernmental agreement with the U.S. governing FATCA may be subject to different rules.</div>
    <div style="text-align: justify; margin-top: 6pt;">Investors should consult their tax advisors about the application of FATCA, in particular if they may be classified as financial institutions (or if they hold their Notes through a foreign entity)
      under the FATCA rules.</div>
    <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Proposed Legislation.</font> In 2007, legislation was introduced in Congress that, if it had been enacted, would have required holders of Notes purchased after the
      bill was enacted to accrue interest income over the term of the Notes despite the fact that there will be no interest payments over the term of the Notes.</div>
    <div style="text-align: justify; margin-top: 6pt;">Furthermore, in 2013, the House Ways and Means Committee released in draft form certain proposed legislation relating to financial instruments. If it had been enacted, the effect of this legislation
      generally would have been to require instruments such as the Notes to be marked to market on an annual basis with all gains and losses to be treated as ordinary, subject to certain exceptions.</div>
    <div style="text-align: justify; margin-top: 6pt;">It is impossible to predict whether any similar or identical bills will be enacted in the future, or whether any such bill would affect the tax treatment of your Notes. You are urged to consult your
      tax advisor regarding the possible changes in law and their possible impact on the tax treatment of your Notes.</div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">Both U.S. and non-U.S. holders are urged to consult their tax advisors concerning the application of U.S. federal income tax laws to an investment in the Notes, as well as any tax
      consequences of the purchase, beneficial ownership and disposition of the Notes arising under the laws of any state, local, non-U.S. or other taxing jurisdiction (including that of TD and those of the Reference Asset Constituent Issuers).</div>
    <div style="font-weight: bold; text-align: justify;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">18</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 10pt; color: rgb(0, 176, 80); font-size: 16pt;">Supplemental Plan of Distribution (Conflicts of Interest)</div>
    <div style="text-align: justify; margin-top: 6pt;">
      <div style="margin-top: 6pt;">We have appointed TDS, an affiliate of TD, as the Agent for the sale of the Notes. Pursuant to the terms of a distribution agreement, TDS will purchase the Notes from TD at the public offering price less an underwriting
        discount of up to the underwriting discount specified on the cover page hereof with respect to a portion of the Notes and will use all of that commission to allow selling concessions to other registered broker-dealers in connection with the
        distribution of the Notes. The underwriting discount represents the selling concessions for other dealers in connection with the distribution of the Notes. The total &#8220;Underwriting Discount&#8221; and &#8220;Proceeds to TD&#8221; specified on the cover hereof reflect
        the aggregate of the underwriting discount at the time TD established any hedge positions on or prior to the Pricing Date, which was variable and fluctuated depending on market conditions at such times. The Notes were generally offered to the
        public at the public offering price, provided that certain fee based advisory accounts may have agreed to purchase the Notes for as low as the price specified on the cover hereof and such registered broker-dealers may have agreed to forgo, in their
        sole discretion, some or all of their selling concessions in connection with such sales. TD will also periodically pay one or more unaffiliated dealers a structuring fee and/or marketing fee per Note in the amount indicated on the cover hereof with
        respect to $52,000.00 aggregate Principal Amount of the Notes. We or one of our affiliates will also pay a fee to iCapital Markets LLC, who is acting as a dealer in connection with the distribution of the Notes. TD will reimburse TDS for certain
        expenses in connection with its role in the offer and sale of the Notes, and TD will pay TDS a fee in connection with its role in the offer and sale of the Notes.</div>
    </div>
    <div style="text-align: justify; margin-top: 6pt;"><font style="font-style: italic;">Conflicts of Interest. </font>TDS is an affiliate of TD and, as such, has a &#8220;conflict of interest&#8221; in this offering within the meaning of Financial Industry
      Regulatory Authority, Inc. (&#8220;FINRA&#8221;) Rule 5121. If any other affiliate of TD participates in this offering, that affiliate will also have a &#8220;conflict of interest&#8221; within the meaning of FINRA Rule 5121. In addition, TD will receive the net proceeds
      from the initial public offering of the Notes, thus creating an additional conflict of interest within the meaning of FINRA Rule 5121. This offering of the Notes will be conducted in compliance with the provisions of FINRA Rule 5121. In accordance
      with FINRA Rule 5121, neither TDS nor any other affiliate of ours is permitted to sell the Notes in this offering to an account over which it exercises discretionary authority without the prior specific written approval of the account holder.</div>
    <div style="text-align: justify; margin-top: 6pt;">We, TDS, another of our affiliates or third parties may use this pricing supplement in the initial sale of the Notes. In addition, we, TDS, another of our affiliates or third parties may use this
      pricing supplement in a market-making transaction in the Notes after their initial sale. <font style="font-weight: bold; font-style: italic;">If a purchaser buys the Notes from us, TDS, another of our affiliates or third parties, this pricing
        supplement is being used in a market-making transaction unless we, TDS, another of our affiliates or third parties informs such purchaser otherwise in the confirmation of sale.</font></div>
    <div style="text-align: justify; margin-top: 12pt; font-weight: bold;">Prohibition on Sales to EEA Retail Investors</div>
    <div style="text-align: justify; margin-top: 6pt;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the European Economic Area (the
      &#8220;EEA&#8221;). For these purposes, a retail investor means a person who is one (or more) of: (i) a retail client as defined in point (11) of Article 4(1) of Directive 2014/65/EU (as amended, &#8220;MiFID II&#8221;); (ii) a customer within the meaning of Directive (EU)
      2016/97, where that customer would not qualify as a professional client as defined in point (10) of Article 4(1) of MiFID II; or (iii) not a qualified investor as defined in Regulation (EU) 2017/1129, as amended. Consequently no key information
      document required by Regulation (EU) No 1286/2014 (the &#8220;EU PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the EEA has been prepared and therefore offering or selling the Notes or
      otherwise making them available to any retail investor in the EEA may be unlawful under the EU PRIIPs Regulation.</div>
    <div style="text-align: justify; margin-top: 12pt; font-weight: bold;">Prohibition on Sales to United Kingdom Retail Investors</div>
    <div style="text-align: justify; margin-top: 6pt;">The Notes are not intended to be offered, sold or otherwise made available to and should not be offered, sold or otherwise made available to any retail investor in the United Kingdom (&#8220;UK&#8221;). For these
      purposes, a retail investor means a person who is one (or more) of: (i) a retail client, as defined in point (8) of Article 2 of Regulation (EU) No 2017/565 as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018 (the
      &#8220;EUWA&#8221;); or (ii) a customer within the meaning of the provisions of the Financial Services and Markets Act 2000 (the &#8220;FSMA&#8221;) and any rules or regulations made under the FSMA to implement Directive (EU) 2016/97, where that customer would not qualify
      as a professional client, as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of domestic law by virtue of the EUWA. Consequently no key information document required by Regulation (EU) No 1286/2014 as it forms
      part of domestic law by virtue of the EUWA (the &#8220;UK PRIIPs Regulation&#8221;) for offering or selling the Notes or otherwise making them available to retail investors in the UK has been prepared and therefore offering or selling the Notes or otherwise
      making them available to any retail investor in the UK may be unlawful under the UK PRIIPs Regulation.</div>
    <div style="text-align: justify;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">19</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 10pt; color: rgb(0, 176, 80); font-size: 16pt;">Additional Information Regarding the Estimated Value of the Notes</div>
    <div style="text-align: justify; margin-top: 6pt;">The final terms for the Notes were determined on the Pricing Date, based on prevailing market conditions, and are specified elsewhere in this pricing supplement.</div>
    <div style="text-align: justify; margin-top: 6pt;">The economic terms of the Notes are based on our internal funding rate (which is our internal borrowing rate based on variables such as market benchmarks and our appetite for borrowing), and several
      factors, including any sales commissions expected to be paid to TDS or another affiliate of ours, any selling concessions, discounts, commissions or fees expected to be allowed or paid to non-affiliated intermediaries, the estimated profit that we or
      any of our affiliates expect to earn in connection with structuring the Notes, estimated costs which we may incur in connection with the Notes and the estimated cost which we may incur in hedging our obligations under the Notes. Because our internal
      funding rate generally represents a discount from the levels at which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our benchmark debt securities trade
      in the secondary market is expected to have had an adverse effect on the economic terms of the Notes.</div>
    <div style="text-align: justify; margin-top: 6pt;">On the cover page of this pricing supplement, we have provided the estimated value for the Notes. The estimated value was determined by reference to our internal pricing models which take into account
      a number of variables and are based on a number of assumptions, which may or may not materialize, typically including volatility, interest rates (forecasted, current and historical rates), price-sensitivity analysis, time to maturity of the Notes and
      our internal funding rate. For more information about the estimated value, see &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity&#8221; herein. Because our internal funding rate generally represents a discount from the levels at
      which our benchmark debt securities trade in the secondary market, the use of an internal funding rate for the Notes rather than the levels at which our benchmark debt securities trade in the secondary market is expected, assuming all other economic
      terms are held constant, to increase the estimated value of the Notes. For more information see the discussion under &#8220;Additional Risk Factors &#8212; Risks Relating to Estimated Value and Liquidity &#8212; The Estimated Value of Your Notes Is Based on Our
      Internal Funding Rate.&#8221;</div>
    <div style="text-align: justify; margin-top: 6pt;">Our estimated value of the Notes is not a prediction of the price at which the Notes may trade in the secondary market, nor will it be the price at which the Agent may buy or sell the Notes in the
      secondary market. Subject to normal market and funding conditions, the Agent or another affiliate of ours intends to offer to purchase the Notes in the secondary market but it is not obligated to do so.</div>
    <div style="font-weight: 400;">
      <div style="text-align: justify; margin-top: 6pt; margin-bottom: 6pt;">Assuming that all relevant factors remain constant after the Pricing Date, the price at which the Agent may initially buy or sell the Notes in the secondary market, if any, may
        exceed our estimated value on the Pricing Date for a temporary period expected to be approximately 3 months after the Issue Date because, in our discretion, we may elect to effectively reimburse to investors a portion of the estimated cost of
        hedging our obligations under the Notes and other costs in connection with the Notes which we will no longer expect to incur over the term of the Notes. We made such discretionary election and determined this temporary reimbursement period on the
        basis of a number of factors, including the tenor of the Notes and any agreement we may have with the distributors of the Notes. The amount of our estimated costs which we effectively reimburse to investors in this way may not be allocated ratably
        throughout the reimbursement period, and we may discontinue such reimbursement at any time or revise the duration of the reimbursement period after the Issue Date of the Notes based on changes in market conditions and other factors that cannot be
        predicted.</div>
    </div>
    <div style="text-align: justify; margin-top: 6pt; font-weight: bold;">We urge you to read the &#8220;Additional Risk Factors&#8221; herein.</div>
    <div style="font-weight: bold; text-align: justify;"> <br>
    </div>
    <div class="BRPFPageBreakArea" style="clear: both; margin-top: 9pt; margin-bottom: 9pt;">
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">20</font></div>
              </td>
            </tr>

        </table>
      </div>
      <div class="BRPFPageBreak" style="page-break-after: always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
      <div class="BRPFPageHeader" style="width: 100%;"></div>
    </div>
    <div style="text-align: justify; margin-bottom: 10pt; color: rgb(0, 176, 80); font-size: 16pt;">Validity of the Notes</div>
    <div style="text-align: justify; margin-top: 12pt; margin-bottom: 6pt;">In the opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP, as special products counsel to TD, when the Notes offered by this pricing supplement have been executed and
      issued by TD and authenticated by the trustee pursuant to the indenture and delivered, paid for and sold as contemplated herein, the Notes will be valid and binding obligations of TD, enforceable against TD in accordance with their terms, subject to
      applicable bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium, receivership or other laws relating to or affecting creditors&#8217; rights generally, and to general principles of equity (regardless of whether enforcement is sought in
      a proceeding at law or in equity). This opinion is given as of the date hereof and is limited to the laws of the State of New York. Insofar as this opinion involves matters governed by Canadian law, Fried, Frank, Harris, Shriver &amp; Jacobson LLP
      has assumed, without independent inquiry or investigation, the validity of the matters opined on by McCarthy T&#233;trault LLP, Canadian legal counsel for TD, in its opinion expressed below. In addition, this opinion is subject to customary assumptions
      about the trustee&#8217;s authorization, execution and delivery of the indenture and, with respect to the Notes, authentication of the Notes and the genuineness of signatures and certain factual matters, all as stated in the opinion of Fried, Frank,
      Harris, Shriver &amp; Jacobson LLP filed as Exhibit 5.3 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
    <div style="margin: 12pt 0px 0px; text-align: justify;">In the opinion of McCarthy T&#233;trault LLP, the issue and sale of the Notes has been duly authorized by all necessary corporate action on the part of TD, and when this pricing supplement has been
      attached to, and duly notated on, the master note that represents the Notes, the Notes will have been validly executed and issued and, to the extent validity of the Notes is a matter governed by the laws of the Province of Ontario, or the laws of
      Canada applicable therein, will be valid obligations of TD, subject to the following limitations: (i) the enforceability of the indenture is subject to bankruptcy, insolvency, reorganization, arrangement, winding up, moratorium and other similar laws
      of general application limiting the enforcement of creditors&#8217; rights generally; (ii) the enforceability of the indenture is subject to general equitable principles, including the fact that the availability of equitable remedies, such as injunctive
      relief and specific performance, is in the discretion of a court; (iii) courts in Canada are precluded from giving a judgment in any currency other than the lawful money of Canada; and (iv) the enforceability of the indenture will be subject to the
      limitations contained in the Limitations Act, 2002 (Ontario), and such counsel expresses no opinion as to whether a court may find any provision of the indenture to be unenforceable as an attempt to vary or exclude a limitation period under that Act.
      This opinion is given as of the date hereof and is limited to the laws of the Province of Ontario and the federal laws of Canada applicable thereto. In addition, this opinion is subject to: (i) the assumption that the senior indenture has been duly
      authorized, executed and delivered by, and constitutes a valid and legally binding obligation of, the trustee, enforceable against the trustee in accordance with its terms; and (ii) customary assumptions about the genuineness of signatures and
      certain factual matters all as stated in the letter of such counsel dated December 20, 2024, which has been filed as Exhibit 5.2 to the registration statement on Form F-3 filed by TD on December 20, 2024.</div>
    <div><br>
    </div>
    <div><br>
    </div>
    <div>
      <div class="BRPFPageFooter" style="width: 100%;">
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: Arial; font-size: 9pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt;">TD SECURITIES (USA) LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top;">
                <div style="font-size: 8pt; text-align: right;">P-<font class="BRPFPageNumber">21</font></div>
              </td>
            </tr>

        </table>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"> </div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-FILING FEES
<SEQUENCE>2
<FILENAME>exfilingfees.htm
<DESCRIPTION>EXHIBIT 107.1
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Mon Oct 20 19:35:38 UTC 2025 -->
<!--?xml version="1.0" encoding="ASCII"?-->
<!-- Generated by CompSci Transform (tm) - http://www.compsciresources.com -->
<!-- Created: Tue Mar 04 23:02:01 UTC 2025 -->
<html xmlns:compsci="http://compsciresources.com" xmlns:dei="http://xbrl.sec.gov/dei/2025" xmlns:ffd="http://xbrl.sec.gov/ffd/2025" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-types="http://fasb.org/us-types/2025" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title> </title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc. Document created using Broadridge PROfile 25.1.1.5279 Copyright 1995 - 2025 Broadridge -->



<meta content="text/html" http-equiv="Content-Type"/>
</head>
<body><div style="font-family: Arial; font-size: 9pt; text-align: left; color: rgb(0, 0, 0);"><div>
    <div style="color: rgb(0, 0, 0); font-family: 'Times New Roman'; font-size: medium; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: normal; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; padding-bottom: 20px;">

      <div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;">Calculation of Filing Fee Tables</div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="ffd:FormTp" id="ixv-32">F-3</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 20pt; font-weight: bold;"><ix:nonNumeric contextRef="c0" name="dei:EntityRegistrantName" id="ixv-33">TORONTO DOMINION BANK</ix:nonNumeric></div>
        <div style="text-align: center; font-family: 'Times New Roman', serif; font-size: 12pt; font-weight: bold;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <div style="text-align: center; font-family: Arial; font-size: 12pt; font-weight: bold;">Narrative Disclosure</div>
        <div style="text-align: center; font-family: 'Times New Roman',serif; font-size: 12pt;"><span style="font-size: 10pt;">&#160; </span><br/>
        </div>
        <ix:nonNumeric contextRef="c0" escape="true" name="ffd:NrrtvDsclsr" id="ixv-26"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is $<ix:nonFraction contextRef="c0" decimals="2" format="ixt:num-dot-decimal" name="ffd:NrrtvMaxAggtOfferingPric" scale="0" unitRef="usd" id="ixv-34">62,000.00</ix:nonFraction>. The prospectus is a <ix:nonNumeric contextRef="c0" format="ixt:fixed-true" name="ffd:FnlPrspctsFlg" id="ixv-35">final prospectus</ix:nonNumeric> for the related offering<span>.</span></div></ix:nonNumeric>
        <div><br/>
        </div>
      </div>
    </div>
  </div></div><div style="display: none"><ix:header>
<ix:hidden>
<ix:nonNumeric contextRef="c0" name="ffd:CombinedProspectusTableNa" id="ixv-38">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="dei:EntityCentralIndexKey" id="ixv-39">0000947263</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:FeeExhibitTp" id="ixv-40">EX-FILING FEES</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OfferingTableNa" id="ixv-41">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:OffsetTableNa" id="ixv-42">N/A</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:RegnFileNb" id="ixv-43">333-283969</ix:nonNumeric>
<ix:nonNumeric contextRef="c0" name="ffd:SubmissnTp" id="ixv-44">424B3</ix:nonNumeric>
</ix:hidden>
<ix:references><link:schemaRef xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd" xlink:type="simple"/></ix:references>
<!-- [WMV6][y/KIewKfKHo4dWQzR70/4hIKuNChv9EF7/CqJxJN+mjZkL/azkjMxYMTtnBcsHbgkTW1VxT4wNQ7CZqPhsXMLKxWWnLTwmlXUevKXDbLbUMyn53WEMDoDg6HxTS4gyo7xLmXVcK3Z4cmarC5RUu0KMrB1ZiaBghKM4JP7Uveo7BpGnl2X9kj7ufYZqunJkezzE264sVSfkmaLTd5SzzuiQEWk+wwF+pfJ3x0o/wLVdYerOYGR8j/Tn206rze9i26iKNbBWnbK1b2mwB5P4XlbZFF/ukXYsq24cOpfzHimNeyY1+wb6OJyHCfAYF/DNePCStQoGcZg7pRfks5tSDSin/roVHGpjTCK7diGCUGowdgfFSnCYCrvyM/rL1C/TvtIsXZhVnuIrI4C/O7ALZ5GtPdQewb6YzSo6hYkCU42PaLqYAa092ItO8qGluUTN6y6I/3AA==] CSR-->
<ix:resources xmlns="http://www.xbrl.org/2003/instance"><xbrli:context xmlns="" id="c0">
  <xbrli:entity>
    <xbrli:identifier scheme="http://www.sec.gov/CIK">0000947263</xbrli:identifier>
  </xbrli:entity>
  <xbrli:period>
    <xbrli:startDate>2025-10-16</xbrli:startDate>
    <xbrli:endDate>2025-10-16</xbrli:endDate>
  </xbrli:period>
</xbrli:context><xbrli:unit xmlns="" id="usd">
  <xbrli:measure>iso4217:USD</xbrli:measure>
</xbrli:unit></ix:resources></ix:header>

</div></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image0.jpg
<TEXT>
begin 644 image0.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" !) %$# 2(  A$! Q$!_\0
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MVO/^C5OVD/\ PQWQ._\ F7KL_L+//^A-FO\ X;L7_P#*3U_]2.-/^B0XH_\
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M_%.'_J\O_G//_P >3_-_HK_2 HH_XEG_ .JV_P#-;_\ P\'_ !3A_P"KR_\
(G//_ ,>3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>image1.jpg
<TEXT>
begin 644 image1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $^ ?D# 2(  A$! Q$!_\0
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M-%<]]H\5?\^&C_\ @7)_\11]H\5?\^&C_P#@7)_\10!T-%<]]H\5?\^&C_\
M@7)_\11]H\5?\^&C_P#@7)_\10!T-%<]]H\5?\^&C_\ @7)_\11]H\5?\^&C
M_P#@7)_\10!T-%<]]H\5?\^&C_\ @7)_\11]H\5?\^&C_P#@7)_\10!T-%<]
M]H\5?\^&C_\ @7)_\11]H\5?\^&C_P#@7)_\10!T-%<]]H\5?\^&C_\ @7)_
M\11]H\5?\^&C_P#@7)_\10!T-%<]]H\5?\^&C_\ @7)_\11]H\5?\^&C_P#@
M7)_\10!T-%<]]H\5?\^&C_\ @7)_\11]H\5?\^&C_P#@7)_\10!T-%<]]H\5
M?\^&C_\ @7)_\11]H\5?\^&C_P#@7)_\10!T-%<]]H\5?\^&C_\ @7)_\11]
MH\5?\^&C_P#@7)_\10!T-%<]]H\5?\^&C_\ @7)_\11]H\5?\^&C_P#@7)_\
M10!T-%<]]H\5?\^&C_\ @7)_\11]H\5?\^&C_P#@7)_\10!T-%<]]H\5?\^&
MC_\ @7)_\11]H\5?\^&C_P#@7)_\10!T-%<]]H\5?\^&C_\ @7)_\11]H\5?
M\^&C_P#@7)_\10!T-%<]]H\5?\^&C_\ @7)_\11]H\5?\^&C_P#@7)_\10!T
M-%<]]H\5?\^&C_\ @7)_\11]H\5?\^&C_P#@7)_\10!T-%<]]H\5?\^&C_\
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M "BBB@ HHHH *@OO^/&X_P"N;?RJ>H+[_CQN/^N;?RH R_!'_(GZ+_UYQ?\
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MK_H8='_\#8O_ (JM7[':_P#/M#_W[%'V.U_Y]H?^_8H RO\ A+_#7_0PZ/\
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M4:7=QJ9CD91U5((@H^@R?S-=C<987VD5JM'\WI^%R=>:QZ:+3Q7_ -!G0_\
MP42__)-17EKXI%I-OUC1"NQL@:3*"1CU^TUTU07W_'C<?]<V_E7FEF7X)/\
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M1-?TUF9&  N%Y./K0!>\$?\ (GZ+_P!><7_H(K;K$\$_\BAHO_7G%_Z"*VZ
M BL6;P]!):PVGVJ[2S1BSP*R[9LMNPQV[L9]".*VJ* ,230%NKA9[ZZFDEWY
MD5 JI*BR%XU88)^7/4$$]\]*A_X12T$GF1W5Y'+&Q-M(K+FV!)+*F5Z')SNW
M?H*Z&B@""QM(K&SAMK<;885"(.O KE/A0<^%[C_L*:A_Z52UV5<9\)_^17N/
M^PIJ'_I5+0!V=%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M*TY0:II_#^?7_(E=SY<^.?PHN=/U;6/%.EW9V:M>P0,HSN@$^Z.;/8JQ9?\
MOK%?3]M%Y-M%$3DH@7/K@4]E### $>AI:57$SK0C&?V1I6"BBBN<84444 %%
M%% !1110 5!??\>-Q_US;^53U!??\>-Q_P!<V_E0!E^"/^1/T7_KSB_]!%;=
M8G@C_D3]%_Z\XO\ T$5MT %%%% !1110 5QGPG_Y%>X_["FH?^E4M=G7&?"?
M_D5[C_L*:A_Z52T =G1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MAW?>%I=.6WEM;N:87D,B9+QKLQM.<@_,WXUR.J>%4^./C+Q3>37"?V)I</\
M9ND7EO.&47  =G*C[RG>,^P !XKH]5T32_B3\;=7L]3C,FG^'M*6TEB/'G27
M +!@>P5>01@YQ79?"7X?0?#G0;S2[2^EO8[B\>Z#R(%*@JJA>.N HY[G/2E[
M6&'I+DTJ6_/7\OS"S;\CI?#&D1:!X=TS2+<EH;&VCMU).<A5 S6I117G-MN[
M+"BBBD 4444 %%%% !1110 4444 %07W_'C<?]<V_E4]07W_ !XW'_7-OY4
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M'B/_ *&=?_!<G_Q5 '245S?]D>(_^AG7_P %R?\ Q5']D>(_^AG7_P %R?\
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MAL]6(M[:97!9T",/,P,[>6&,\\'CI7J?]D>(O^AG7_P7)_C1_9'B+_H9E_\
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M@#I**YO^R/$?_0SK_P""Y/\ XJC^R/$?_0SK_P""Y/\ XJ@#I**YO^R/$?\
MT,Z_^"Y/_BJ/[(\1_P#0SK_X+D_^*H Z2H+[_CQN/^N;?RK"_LCQ'_T,Z_\
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M8H_M*G<I243MYD84$*JMG( #, /]H^M $^GZO'-X?@U2=6CC:$2NJ*7*^N
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M\)KHG_/2_P#_  6W/_QNC_A-=$_YZ7__ (+;G_XW7244 <W_ ,)KHG_/2_\
M_!;<_P#QNC_A-=$_YZ7_ /X+;G_XW7244 <W_P )KHG_ #TO_P#P6W/_ ,;H
M_P"$UT3_ )Z7_P#X+;G_ .-UTE% '-_\)KHG_/2__P#!;<__ !NC_A-=$_YZ
M7_\ X+;G_P"-UTE% '-_\)KHG_/2_P#_  6W/_QNC_A-=$_YZ7__ (+;G_XW
M7244 <W_ ,)KHG_/2_\ _!;<_P#QNC_A-=$_YZ7_ /X+;G_XW7244 <W_P )
MKHG_ #TO_P#P6W/_ ,;H_P"$UT3_ )Z7_P#X+;G_ .-UTE% '-_\)KHG_/2_
M_P#!;<__ !NC_A-=$_YZ7_\ X+;G_P"-UTE% '-_\)KHG_/2_P#_  6W/_QN
MC_A-=$_YZ7__ (+;G_XW7244 <W_ ,)KHG_/2_\ _!;<_P#QNC_A-=$_YZ7_
M /X+;G_XW7244 <W_P )KHG_ #TO_P#P6W/_ ,;H_P"$UT3_ )Z7_P#X+;G_
M .-UTE% '-_\)KHG_/2__P#!;<__ !NHKOQGHSVLR+)?99& SIUR.W_7.NIJ
M"^_X\;C_ *YM_*@#+\$_\BAHW_7I%_Z"*VZQ/!'_ ")^B_\ 7G%_Z"*VZ "B
MBB@ HHHH *XSX3_\BO<?]A34/_2J6NSKC/A/_P BO<?]A34/_2J6@#KKJWAN
MK:6WN8DF@E4I)&ZAE=3P00>HHM+:&SM8K:UB2&WA01QQQJ%5% P  .@ J6BB
MX!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *@OO^/&X_ZYM_*IZ@OO^/&X
M_P"N;?RH R_!'_(GZ+_UYQ?^@BMNL3P1_P B?HO_ %YQ?^@BMN@ HHHH *R/
M$,4Y;3KFWMGNOLMQYKPQE0S QNO&X@9!8=2.,UKT&@#'T?3[BW\,VM@]P]O<
MI (S+#M9HV]MP*G'N"*XWPMX+\3:=I;PKXPO[+?=7$QA%G:28WS.P.[9W!!]
ML]!TKJ->U2Z^5-$47C6]RL5]';LK31J5W !6( SE<D]%)(S5_0]2?4H9C-;_
M &>X@E:&5%D$B[A@_*V!D8([#G(H Y__ (1GQ1_T/NH?^"ZT_P#C='_",^*/
M^A]U#_P76G_QNNSHH XS_A&?%'_0^ZA_X+K3_P"-T?\ ",^*/^A]U#_P76G_
M ,;KLZCN9H[:WEGN'6.&)2[NQP%4#))_"@#A-7\/>,X=,N9--\;7MQ>K&3#$
M^GV@#MV!.SBKG_",^*.WCW4/_!=:?_&Z=KOB>33M5B,*Q3V<UGY]N6F$<4H&
M3)A]IRP79M7C.X\\9'6VLPN+:*90RK(@<!A@C(SS[T <A_PC/BC_ *'W4/\
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MB2&091P" P]1[4 <G_PC/BC_ *'W4/\ P76G_P ;H_X1GQ1_T/NH?^"ZT_\
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MC#[;&5.[:1D"/L6'!(]#ZX% &/JFMC5'C-O-J%G8QJ1,PMR&0O@Q2.A!W0L
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MY@RD_P!WDD8KT",%5 )+$#&X]34=I!]GMXX1)+($4#?*^YF]R?6IJ "BBC-
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M64[<;E8',C$G.YAG&<UZ)1B@""SMH[2UC@AW>7&, NQ8GW)/)-3T44 %%%%
M&#XMLYKNWM"MJ+ZUAG#W-D<?OX]I&,'@D$AMIX./7%97AGP[&NH7=\(;ZPLY
M)E>&R:78/E4#YD!( ##@9Z>V .SQ1B@  Q1110 4&BB@#C/$FF^;JUU+?Z1/
MJD,\2I:RV^TR6K $$ D@IDX.X?0]!6KX3T+^Q]-M5FFGENEMXXGWS%TCP!E4
M'0+FM[%% !1110 4V4%HV"ML8@@-C./>G44 ><0>''N9M+MY=,N;'4K6;?>:
ME X19QL8;PX.YF)*D9&1DCID'O[&T2TM4@C:1E7)+2.69B3DDD]22:L8%% !
M1110 5B^*K.:\TY%AA%RB3))-:D@"XC'WDYX]\'@XP>#6U1B@#B?#_AR&35+
MR]CMK_2[%S%Y=GYGEJQ4'.44D!,D8''?L<5VPHQ10 4444 %<CXETX2ZO+<:
MAI,NJVDENL<'DA3):R MN*Y(V[LK\P.1MY[5UU&,T <[X/T%M(TVU^TS3R72
MPK&RO,72+ID(.PR/T]*Z(48HH ****  UYRWAUYWL[6;3;B+5(KI9;C5H6""
MX0-DN7!W%B,84CY3TX%>C48H JZ;9)8VJPQO+)@EF>9R[LQZDFK5%% !1110
M!D>*+.>]TAXK9!,0Z.]NS;1.@8%HR>V1^'8\$USVC^'(+G6+F[@L[[2-/:*-
A/LH?R1(P+%AL4D!.1TQSG'4Y[BB@  Q1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>image2.jpg
<TEXT>
begin 644 image2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" $_ ?L# 2(  A$! Q$!_\0
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MT.THJ]=V2>3QTH Z?^V=.%S<6YNXA+;J7E!. H'7GIQW]*B3Q#I3BW*WL?\
MI#%8P00<@XY&/EY]<5SE]H&HWGVBW\J..-#<RQRM(")#+R$(ZC'0D\>E13:'
MJMQ?:G<FT2/^URBNAE4FU"[!DX^]D+GY?44 =[F@'-<Y\0IKZR\&ZOJ&E7SV
M5U96DUTKK&C[BD;,%(8'@D#IS5;2='U"\TNSN9/$>JJ\T*2,%$6 2H/'R>]
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M_0RZM^47_P 10!T5%<[_ ,(]>_\ 0RZM^47_ ,11_P (]>_]#+JWY1?_ !%
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M_0RZM^47_P 10!T5%<[_ ,(]>_\ 0RZM^47_ ,11_P (]>_]#+JWY1?_ !%
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M_0RZM^47_P 10!T5%<[_ ,(]>_\ 0RZM^47_ ,11_P (]>_]#+JWY1?_ !%
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MW-<_Z%.\_P# RW_^+KI** .;_MS7/^A3O/\ P,M__BZ/[<US_H4[S_P,M_\
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M@#F_[<US_H4[S_P,M_\ XNC^W-<_Z%.\_P# RW_^+KI** .;_MS7/^A3O/\
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M,^A_^#"+_P"*H Z&BN>_X3?PI_T,^A_^#"+_ .*H_P"$W\*?]#/H?_@PB_\
MBJ .AHKGO^$W\*?]#/H?_@PB_P#BJ/\ A-_"G_0SZ'_X,(O_ (J@#H:*Y[_A
M-_"G_0SZ'_X,(O\ XJC_ (3?PI_T,^A_^#"+_P"*H Z&BN>_X3?PI_T,^A_^
M#"+_ .*H_P"$W\*?]#/H?_@PB_\ BJ .AHKGO^$W\*?]#/H?_@PB_P#BJ/\
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M]!C7_P#P92?XT =)17-_\(C#_P!!C7__  92?XT?\(C#_P!!C7__  92?XT
M=)17-_\ "(P_]!C7_P#P92?XT?\ "(P_]!C7_P#P92?XT =)17-_\(C#_P!!
MC7__  92?XT?\(C#_P!!C7__  92?XT =)17-_\ "(P_]!C7_P#P92?XT?\
M"(P_]!C7_P#P92?XT =)17-_\(C#_P!!C7__  92?XT?\(C#_P!!C7__  92
M?XT =)17-_\ "(P_]!C7_P#P92?XT?\ "(P_]!C7_P#P92?XT =)17-_\(C#
M_P!!C7__  92?XT?\(C#_P!!C7__  92?XT =)17-_\ "(P_]!C7_P#P92?X
MT?\ "(P_]!C7_P#P92?XT =)17-_\(C#_P!!C7__  92?XT?\(C#_P!!C7__
M  92?XT =)17-_\ "(P_]!C7_P#P92?XT?\ "(P_]!C7_P#P92?XT =)17-_
M\(C#_P!!C7__  92?XT?\(C#_P!!C7__  92?XT =)17-_\ "(P_]!C7_P#P
M92?XT?\ "(P_]!C7_P#P92?XT =)17-_\(C#_P!!C7__  92?XT?\(C#_P!!
MC7__  92?XT =)17-_\ "(P_]!C7_P#P92?XTG_"(P_]!C7_ /P92?XT =+2
M9KPCX]>(+7P%X=:"P\0:_'XCNXP]DK7DDB "10Y;)P/E+8SWKS;5_&7Q FM[
M:'3WU2SNM4MO[6L)3J1D"V21NT@8-P6.W?[ X KLHX&K5BIZ)/N2Y):'T_-X
MST"#Q='X8FU&)-;DC$B6Q!RP() !Z9P,X]*X;XP^/-8T/6M.T7P?:->:M#$=
M6OHROR_8X]VY<^KE2..>GK7G)^$(C^',WCX^)-3N/%7V"/68+N1L>25B64KU
M)8X! )/<<5:_9OTB_P#&]GXC\1>)K_5FGNVCLDNX[MHVF14.Y3CJ!E>V.3[U
MLL/1IQ=6+YE'1KS_ ,A7>QF:G\1+SQ[XJM_&&@A]/TKP<T+S0SON,T<\FR1\
M#@80<@GH*^BO!/BO3?&.B?VMHS2M9&:2%7D7;NV'!8#T/:OG_P +_"Z.V^!N
MOZCI8UEM:U"WGB:RCD8"7RIY%0>6!EB5'0_@*YIK?4_"WA74_!NGZK?VVM77
M]G&TL6N3%G[8@$T93@9#\$GIN]JWJT:.(7+1TY79>G7\1)M;GV(&!Z'-+7S3
M\ ;6_E\3>)]!\9:SK%OXA@,(C@6ZDA:2&-2NX 8RN"F#Z$'O7N/_  B4/_08
MU_\ \&4G^->9B*+H5'"]RT[JYTM&:X?P_IVEZ_:W%QINN>(9(H+F6T<G4)1^
M\C8JV.>1D=:YOXNWEOX \)C51J6N3S/<Q6Z1OJ<N/F;YB<'/"AOQQ41IRG)0
M2U'?J>N45XUXB\6^$/#\FGMJ/B+Q&MI?Z>=1MKE=0E*R)D *!G)8YR![5U6G
MV>C7WAF/Q!!XAUW^R7MOM?GMJ4H"QA=Q)YXP <_2G*E.*4FM&*Z.[KG_ !-X
MPT'PQ<Z?!KNI0V<M_+Y5NLA^\?4^@Z#)XYKB)]<\)CP5J?BFR\4Z[>Z58$QR
M/#J,P+2#;A!G&2=RX[<UX_!IEI\8[3QKKD5IJ<D>E:>L.EF^OVE99AO=N >X
MV_+R,UO0PKDW*JFHK1OS$Y=CZV!!Z5Y?\1UO=:^)7@?P]:W-M#:0RMKER&7=
M(WV=TV*/3.\CGT/IBO-_AMK.MZ=J2VOQ3\2W]M;WND1:K8R)?O'Y:%MI5PH'
MS$,..VWWKK_AQHEGXJ\7>+M?74M8:.SNAHUI*;UQ*J1*&D!;KM+OD"G[!T).
M3U26_34+W/:12US?_"(P_P#08U__ ,&4G^-'_"(P_P#08U__ ,&4G^-<91TE
M%<W_ ,(C#_T&-?\ _!E)_C1_PB,/_08U_P#\&4G^- '245S?_"(P_P#08U__
M ,&4G^-'_"(P_P#08U__ ,&4G^- '245S?\ PB,/_08U_P#\&4G^-'_"(P_]
M!C7_ /P92?XT =)17-_\(C#_ -!C7_\ P92?XT?\(C#_ -!C7_\ P92?XT .
MTO\ Y'?7_P#KWM?_ &I715R7A>Q73_%>NVZ7%U.!!;'?<S&5^?,_B/.*ZV@
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M/^"&IT]%8USX:TJY\-?\(_/:EM($2P^1YKCY%Q@;L[NP[U6\)^#="\)?:/\
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MH YOSO%__/AH'_@;-_\ &J/.\7_\^&@?^!LW_P :KI** .;\[Q?_ ,^&@?\
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M3^,/B;;>)K+5H;L?9=)ATNZ-M'&B (<"-L\LQZCD'.<U<,+R7G7T2Z=7Y?\
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MAK?_ ();W_XU1_PF.E_\\-;_ /!+>_\ QJ@#HJ*YW_A,=+_YX:W_ ."6]_\
MC5'_  F.E_\ /#6__!+>_P#QJ@#HJ*YW_A,=+_YX:W_X);W_ .-4?\)CI?\
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M: .EHKFO^$&\-_\ 0*A_[Z;_ !H_X0;PW_T"H?\ OIO\: .EHKFO^$&\-_\
M0*A_[Z;_ !H_X0;PW_T"H?\ OIO\: .EHKFO^$&\-_\ 0*A_[Z;_ !H_X0;P
MW_T"H?\ OIO\: .EHKFO^$&\-_\ 0*A_[Z;_ !H_X0;PW_T"H?\ OIO\: .E
MHKFO^$&\-_\ 0*A_[Z;_ !H_X0;PW_T"H?\ OIO\: .EHKFO^$&\-_\ 0*A_
M[Z;_ !H_X0;PW_T"H?\ OIO\: .EHKFO^$&\-_\ 0*A_[Z;_ !H_X0;PW_T"
MH?\ OIO\: .EHKFO^$&\-_\ 0*A_[Z;_ !H_X0;PW_T"H?\ OIO\: .EHKFO
M^$&\-_\ 0*A_[Z;_ !H_X0;PW_T"H?\ OIO\: .EHKFO^$&\-_\ 0*A_[Z;_
M !H_X0;PW_T"H?\ OIO\: .EHKFO^$&\-_\ 0*A_[Z;_ !H_X0;PW_T"H?\
MOIO\: .EHKFO^$&\-_\ 0*A_[Z;_ !H_X0;PW_T"H?\ OIO\: 'Z7QXWU[/_
M #[VO_M2NBKD?"^FVFE>+-=M=/A6"W$%LP123R?,SUKKJ "BD9@JDL0 .I)I
MHFB,IB$B&0<E-PR/PH ?C%%-\Q"[('7<HRRYY%-$\1"$2QD/PA##YOIZT 8/
MQ(_Y)WXH_P"P5=?^B6KPW3/VA;VRT],^#[F73+&&%I;A9_F6!E"QN1C +-[X
MQ[U[E\1SCX>>*,?] JZ_]$M4.B>'-%G\'6MC+I5D;2ZL(89XO)4"5 @P&P.<
M9./3M710J4H7]I'F$T^A-X#\6V'C;PO::YI0=+>X++Y<F-\;*Q4JP!]1GZ$'
MO7%?$CXGZAIFJ2^'?!>B7>K:\)(X9)Q"S6MJ[XP)&'?!SVP.2:\VU7Q]KOPK
M\1>)/#.C^'X;B2XU5K^W8JWEK!.$2+!&!]X*O/&<CK7M?PD\'OX+\'P6%TT4
MNIS2/<WL\9)$LKG).3SP,#\*VE1C0_>R5T]E?\_05[Z'GL_Q<\<6?A^XN+GX
M?7(NM+B,FJ22N8H8P,X,>0=XP-Q(SC]:M^%?A%IWB71X]?\ '!O;C7M3WW<@
MBOG$=N9&W1F,# #*FT=QUKV/4;*WU+3[FQOH5GM+F-H9HGZ.C#!!]B#4EO"E
MO!'#"@2*-0B*.@4# %9O$I*U*/*_*X6[GB.E?"?Q[H-N8]%^)EP(HE806]S:
M&2,#G"G<Y]>N/?%>G_#KPZWA3P1HVARRI++9VXCDD085FZDCVR:Z2BLZN(G5
M5I?DD-)(****Q&%%%% !1110 4444 %%%% !1110 4444 %%%% !1UHHH H1
MZ181ZU-JZ6ZKJ,T"VTDX)RT:DLJGMP6/YU?HHHN 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
MSNE?\COK_P#U[VO_ +4KHJYW2O\ D=]?_P"O>U_]J5T5 &+XPLAJ'AV]M_(\
M]BH9(P,Y8$$<?45C"&#2O%EW?PK<>4RR3W\D]F D:B,8,<NP,WW0-H9N_ Q7
M9$9H90RX8 CT/- 'G=]IMW/-?+;64XO#]J>:;RBOGQO_ *M Y&&XX"Y^7VJO
M)ILCWU_);:9<);7+*-+'V5D^SL-FX[2/W.2&.3C/XUZ9BC% ')_%;[8/AWXC
M-@+<G^S[GS?.+#]WY3YVX_B],\5%H9\5_P!BZ?\ 9TT(P_9X]F]YMVW:,9P.
MN*O_ !(_Y)WXI_[!5U_Z):M+PW_R+VE_]>L7_H H YG5]%UW6('AU+3_  U/
M&[1LV6F!8QN'3) SPP! K2SXP_N:!_WW-_A72T8HNP.:SXP_N:!_WW-_A1GQ
MA_<T#_ON;_"NEHH YK/C#^YH'_?<W^%&?&']S0/^^YO\*Z6B@#FL^,/[F@?]
M]S?X49\8?W- _P"^YO\ "NEHH YK/C#^YH'_ 'W-_A1GQA_<T#_ON;_"NEHH
M YK/C#^YH'_?<W^%&?&']S0/^^YO\*Z6B@#FL^,/[F@?]]S?X49\8?W- _[[
MF_PKI:* .:SXP_N:!_WW-_A1GQA_<T#_ +[F_P *Z6B@#FL^,/[F@?\ ?<W^
M%&?&']S0/^^YO\*Z6B@#FL^,/[F@?]]S?X49\8?W- _[[F_PKI:* .:SXP_N
M:!_WW-_A1GQA_<T#_ON;_"NEHH YK/C#^YH'_?<W^%&?&']S0/\ ON;_  KI
M:* .:SXP_N:!_P!]S?X49\8?W- _[[F_PKI:* .:SXP_N:!_WW-_A1GQA_<T
M#_ON;_"NEHH YK/C#^YH'_?<W^%&?&']S0/^^YO\*Z6B@#FL^,/[F@?]]S?X
M49\8?W- _P"^YO\ "NEHH YK/C#^YH'_ 'W-_A1GQA_<T#_ON;_"NEHH YK/
MC#^YH'_?<W^%&?&']S0/^^YO\*Z6B@#FL^,/[F@?]]S?X49\8?W- _[[F_PK
MI:* .:SXP_N:!_WW-_A1GQA_<T#_ +[F_P *Z6B@#FL^,/[F@?\ ?<W^%&?&
M']S0/^^YO\*Z6B@#FL^,/[F@?]]S?X49\8?W- _[[F_PKI:* .:SXP_N:!_W
MW-_A1GQA_<T#_ON;_"NEHH YK/C#^YH'_?<W^%&?&']S0/\ ON;_  KI:* .
M:SXP_N:!_P!]S?X49\8?W- _[[F_PKI:* .:SXP_N:!_WW-_A1GQA_<T#_ON
M;_"NEHH YK/C#^YH'_?<W^%&?&']S0/^^YO\*Z6B@#FL^,/[F@?]]S?X49\8
M?W- _P"^YO\ "NEHH Y'PO\ ;SXLUW^U1:BZ\BVS]F+%,?O,?>YS775SNE?\
MCOK_ /U[VO\ [4KHJ "BLCQ9/=6V@W<]A.+>>,!@^P/QD9&#QR.,\XK,M-2O
M7U] ]P6MY;R6T^S;%VQA(RX<'&[<2.<DC!& * .JHKA=1UW4;7[5<I<AE=KJ
M)(61=D'E<*_3<3W.21Z8J*?6=4M[_5K;[?)(NDE&#M''FZW;#A\*!QN(^3;V
MH W/B1_R3OQ3_P!@JZ_]$M6EX;_Y%[2_^O6+_P! %8GQ5O8[/X=>(_-2X?S=
M.N8E\F!Y<$Q-RVT':OJQP!W-1Z'XKL(=%T^)[36RR6\:DIH]VZDA0."(\$>X
MXH ["BN=_P"$PT__ )\]>_\ !)>?_&J/^$PT_P#Y\]>_\$EY_P#&J .BHKG?
M^$PT_P#Y\]>_\$EY_P#&J/\ A,-/_P"?/7O_  27G_QJ@#HJ*YW_ (3#3_\
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M/7O_  27G_QJC_A,-/\ ^?/7O_!)>?\ QJ@#HJ*YW_A,-/\ ^?/7O_!)>?\
MQJC_ (3#3_\ GSU[_P $EY_\:H Z*BN=_P"$PT__ )\]>_\ !)>?_&J/^$PT
M_P#Y\]>_\$EY_P#&J .BHKG?^$PT_P#Y\]>_\$EY_P#&J/\ A,-/_P"?/7O_
M  27G_QJ@#HJ*YW_ (3#3_\ GSU[_P $EY_\:H_X3#3_ /GSU[_P27G_ ,:H
M Z*BN=_X3#3_ /GSU[_P27G_ ,:H_P"$PT__ )\]>_\ !)>?_&J .BHKG?\
MA,-/_P"?/7O_  27G_QJC_A,-/\ ^?/7O_!)>?\ QJ@#HJ*YW_A,-/\ ^?/7
MO_!)>?\ QJC_ (3#3_\ GSU[_P $EY_\:H Z*BN=_P"$PT__ )\]>_\ !)>?
M_&J/^$PT_P#Y\]>_\$EY_P#&J .BHKG?^$PT_P#Y\]>_\$EY_P#&J/\ A,-/
M_P"?/7O_  27G_QJ@#HJ*YW_ (3#3_\ GSU[_P $EY_\:H_X3#3_ /GSU[_P
M27G_ ,:H Z*BN=_X3#3_ /GSU[_P27G_ ,:H_P"$PT__ )\]>_\ !)>?_&J
M#2O^1WU__KWM?_:E=%7)>%[^+4?%FNW$$=S&A@MEVW-O) _'F?PN V/?%=;0
M!'/#'<1-',BR1L,,K#((]Q5*YT:QN)+J4VZ1W%S$8)+B-0LA4C&-W6M&B@"D
MNDZ>EQ-.MG;B:9/+E?RQEUQC!/<5%'H6E1K;*FG6BK:L6@ B'[LGDD>E:5%
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M9P.ASMZ9>1:A8P7=L6,,R!UW#! /8^] '+?V3XY_Z&G2/_!.?_CU']D^.?\
MH:=(_P#!.?\ X]79T4 <9_9/CG_H:=(_\$Y_^/4?V5XY_P"AITC_ ,$Y_P#C
MU=G3)I4B3=*ZHN0,L<#). /SH X/4K+X@6WV;[-K^E7/F3I')C2"/+0GE_\
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MFLOMGV-DCR)K<L0(V8$D,KY4Y&,!AU&2 "N-)\<_]#3I'_@G/_QZC^R?'/\
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MQ&Q'[O<&Q^[8A@7'&0 &'6M/7=8>RE2.UM?MOEE7O$0_-#"<_/C^+H?E'/\
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M,X_$8R13]*LKN_U*+51/9I87%G%'+#;CS Y1I<*&(QLQ)U R2O&!74*H50
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9+J2[FY+32  G/H , >PJW110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>image3.jpg
<TEXT>
begin 644 image3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  8$!08%! 8&!08'!P8("A *"@D)
M"A0.#PP0%Q08&!<4%A8:'24?&ALC'!86("P@(R8G*2HI&1\M,"TH,"4H*2C_
MVP!# 0<'!PH("A,*"A,H&A8:*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H
M*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"C_P  1" %% @H# 2(  A$! Q$!_\0
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M@-9?]^Q0!NJZO]QE8>QS3JY3PA9V^GZ_XDM;*%(+>.:'9&@PJYB!.!]375T
M%%%% !1110!Q7_-:!_V+_P#[<UVM<5_S6@?]B_\ ^W-=K0 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% '.>'_\ D:O%'_7:#_T2M='7.>'_ /D:O%'_ %V@
M_P#1*UT= !1110 4444 <5_S6@?]B_\ ^W-=K7%?\UH'_8O_ /MS7:T %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MKI:* .:_X2>[_P"A5\0?]\6__P >H_X2>[_Z%7Q!_P!\V_\ \>K(^*_C^V\
MVNB7%T83'>ZBEO,'R62#!,DB@=U^7\Z[F&1)8TDC(9' 92.A![U3A)14FM&%
MSG?^$GN_^A5\0?\ ?-O_ /'J/^$GN_\ H5?$'_?-O_\ 'JZ6BI YK_A)[O\
MZ%7Q!_WS;_\ QZC_ (2>[_Z%7Q!_WS;_ /QZNEHH YK_ (2>[_Z%7Q!_WS;_
M /QZC_A)[O\ Z%7Q!_WS;_\ QZNEHH YK_A)[O\ Z%7Q!_WS;_\ QZC_ (2>
M[_Z%7Q!_WS;_ /QZNEHH YK_ (2>[_Z%7Q!_WS;_ /QZC_A)[O\ Z%7Q!_WS
M;_\ QZNEHH YK_A)[O\ Z%7Q!_WS;_\ QZC_ (2>[_Z%7Q!_WS;_ /QZNEHH
M YK_ (2>[_Z%7Q!_WS;_ /QZC_A)[O\ Z%7Q!_WS;_\ QZNEHH YK_A)[O\
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M2J.,7=="T[H0UX1]BC^(/[1!OH+MWTOPBJ1S6TNX W0,O*#..&"$GOMQ5_\
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M]'_\%$G_ ,D5G?\ -:!_V+__ +<UVM '-_8/%G_0?T?_ ,%$G_R11]@\6?\
M0?T?_P %$G_R17244 <W]@\6?]!_1_\ P42?_)%'V#Q9_P!!_1__  42?_)%
M=)10!S?V#Q9_T']'_P#!1)_\D4?8/%G_ $']'_\ !1)_\D5TE% '-_8/%G_0
M?T?_ ,%$G_R11]@\6?\ 0?T?_P %$G_R17244 <W]@\6?]!_1_\ P42?_)%'
MV#Q9_P!!_1__  42?_)%=)10!S?V#Q9_T']'_P#!1)_\D4?8/%G_ $']'_\
M!1)_\D5TE% '-_8/%G_0?T?_ ,%$G_R11]@\6?\ 0?T?_P %$G_R17244 <W
M]@\6?]!_1_\ P42?_)%'V#Q9_P!!_1__  42?_)%=)10!S?V#Q9_T']'_P#!
M1)_\D4?8/%G_ $']'_\ !1)_\D5TE% '-_8/%G_0?T?_ ,%$G_R11]@\6?\
M0?T?_P %$G_R17244 <W]@\6?]!_1_\ P42?_)%'V#Q9_P!!_1__  42?_)%
M=)10!S?V#Q9_T']'_P#!1)_\D4?8/%G_ $']'_\ !1)_\D5TE% '-_8/%G_0
M?T?_ ,%$G_R11]@\6?\ 0?T?_P %$G_R17244 <W]@\6?]!_1_\ P42?_)%'
MV#Q9_P!!_1__  42?_)%=)10!S?V'Q9_T']'_P#!1)_\D5XG\4_$?B$_%_P5
MX1GU*PEV7UM?B5-/,:K*6=4R/-8L "V1E>M?1YKR+X;Z1'XE\;>,O$NOVMG>
M3VNM-8Z=*T8+0);$@$>A^8<]ZZ<,XQYJDU=)?B]!/L=S]@\6?]!_1_\ P3O_
M /)%+]@\6?\ 0?T?_P %$G_R171BEKF&<W]@\6?]!_1__!1)_P#)%'V#Q9_T
M']'_ /!1)_\ )%=)10!S?V#Q9_T']'_\%$G_ ,D5SOQ%T/Q5J/@+Q!:/K>D2
MK-8S*4&F/&6&T\!O/;'UP?I7HU5]2M5O=/N;5V*I/$T18=0&!&?UJH2Y9*78
M#\_KSP?>>'+CP3>7,\+/KBQ7L*A2PB0R+MW=,G!!(_"O?OA7H?B/0OB]XWTP
MW^GZ?/,!=6Z2VQE26!II"&BC$PV#))P2<9Y]3ZM'\-O#LFB:-8:E9_;FTNSB
MLH;B1BK[(V1A]TC!W1J>/IT)KAO'26NG_M*>"=28&-GTR\-PX).Y(XI2./;)
MKV*N.>,3IOL_PU7Y6,U'EU/2?L'BS_H/Z/\ ^"=__DBO*/AUXJ\1:Q\6O'6@
MKKVGI+;S*R>=822*WE8B?RT\X;%R 3R<DYKN/A)XZ?Q?X4UK7[ML64.HW*V_
M[O:RVR!60,!U;!YKP'P;J]QX&\96/CG6()KF?Q=%<M#%L\L?O+J/:Q..,IN?
MZ;?6N6AAG:I3DO>V7KO^2*;V/IW[#XL_Z#^C_P#@GD_^2*/L7BS/_(?T?_P4
M2?\ R14GC3Q;I/@W3(-0UZ9H+6:Y2U5U7=AVR1GT&%))]JP[GXE:7'\+;CQP
ML<PT]!((T(#,["4Q*.#C!8#GT-<<:4Y)-+=V^8[HQ/A;XN\0^/=$N+N'6M&M
M[RTN)+:YMAI4C>60QVG)G&0R@'\QVKM/L/BS_H/Z/_X*)/\ Y(KYJ^"3>*?!
MWCSP]%K4%SI>B^))Y9Y!)"R+)*4E6.)LC@[@K >C*:^N*WQM!4:EHNZ>HHNZ
M/-_B)X@U_P #^$[S7=1UO2I8X-JK$FDL&D=B  ,W/OD^P)[4OPZUKQ/XT\%Z
M7KT&M:-#]KCR\0TJ1O+<$JRY^T<X(->;^._B!X<^*FK>'O!^G0WTDG_"0QFX
MS& #!&'#,#SP<GJ.@.:/"_BV3P/\==0\"PSVEKX=N-3EO&:15C$?FVPD6)3T
M #E0/7@=ZU6#?LK-6GO\A<VI[9]@\6?]!_1__!1)_P#)%?,'CSQ7XF\*?&J]
M\3RW<<]O;NVCBY2VQ$VV%6>,1>9GY68-RW7GVK[!9@BEG(  R2> *\$T#P['
M\1OAWXL6Q2"1;SQ7/>VDURAVF,31EB.,\HKK^.*6!G"FY2J*\=G\QR5T>;_
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M,'_?3?XUTU%2!S/_  @GAG_H$P?]]-_C1_P@GAG_ *!,'_?3?XUTU% ',_\
M"">&?^@3!_WTW^-'_"">&?\ H$P?]]-_C7344 <S_P ()X9_Z!,'_?3?XT?\
M()X9_P"@3!_WTW^-=-10!S/_  @GAG_H$P?]]-_C1_P@GAG_ *!,'_?3?XUT
MU% ',_\ "">&?^@3!_WTW^-'_"">&?\ H$P?]]-_C7344 <S_P ()X9_Z!,'
M_?3?XT?\()X9_P"@3!_WTW^-=-10!S/_  @GAG_H$P?]]-_C1_P@GAG_ *!,
M'_?3?XUTU% ',_\ "">&?^@3!_WTW^-'_"">&?\ H$P?]]-_C7344 <S_P (
M)X9_Z!,'_?3?XT?\()X9_P"@3!_WTW^-=-10!S/_  @GAG_H$P?]]-_C1_P@
MGAG_ *!,'_?3?XUTU% ',_\ "">&?^@3!_WTW^-'_"">&?\ H$P?]]-_C734
M4 <S_P ()X9_Z!,'_?3?XT?\()X9_P"@3!_WTW^-=-10!S/_  @GAG_H$P?]
M]-_C1_P@GAG_ *!,'_?3?XUTU% ')>#;"VTW7?$EI8PK#;QS0[$4D@9B!/7W
M)KK:YSP__P C5XH_Z[0?^B5KHZ "BBB@ HHHH XK_FM _P"Q?_\ ;FNUKQ7X
ML^/K3X=_$*+5KN!KEY=(2WB@5MI<FYRQS[*"?K@=ZZ7X3_$ZS\>:'->W$"Z7
M.EY]D6"67[Y9=R;2<9)7G ]*V^KU/9^UM[O<5U>QZ+12"D9@N-S 9.!D]:Q&
M.K*USQ#I.@QPOK.H6]D)Y!%$)7P9&)  4=3R1TKSCQ7\;=#T^7Q/I.F2JWB'
M3#Y%K#,I,=W.>-B[>3AOE(..17-P?!?6_%=KK6K?$+4HYO%%TC)I_DR,;>RR
MJX8( /F!';ZG)YKKAAE'WJ[Y5^+)OV/0?%GCW3I/AUXDUCPIJEG?7-A9RR#R
MI-QC89 ++U'(.,^E6_A1X(T_P/X62ST^2:>2Z*W-S/,1NDD*C)X' XX'/7J:
M\#^)/P\N?AL;-/#]RW]A>(8H]%U",L27G92!*VXGJ2S #@8/K7U9;1B&WBB'
M(C4+^0Q55XQI4TJ4KQE^G<%J]1]&*6BN(H3%&*6B@ HHHH **** "BBB@ KS
M#Q1X6DUGXY^%=4N+*273M-TZ:7S]I\M9PXV#/][YL@>U>GT8S5PFX.Z_JX!1
M114 %%%% !1110!Y]\>/^2=R_P#80L/_ $KBKR?]M.53I_AB-'!D66X9E!Y
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MJ3(&"NIRK#/<'O5P>]<[_P )CIO_ #ZZ]_X([W_XU1_PF.F_\^NO?^".]_\
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MA*.BHKG?^$QTW_GUU[_P1WO_ ,:H_P"$QTW_ )]=>_\ !'>__&J .BHKG?\
MA,=-_P"?77O_  1WO_QJC_A,=-_Y]=>_\$=[_P#&J .BHKG?^$QTW_GUU[_P
M1WO_ ,:H_P"$QTW_ )]=>_\ !'>__&J .BHKG?\ A,=-_P"?77O_  1WO_QJ
MC_A,=-_Y]=>_\$=[_P#&J .BHKG?^$QTW_GUU[_P1WO_ ,:H_P"$QTW_ )]=
M>_\ !'>__&J .BHKG?\ A,=-_P"?77O_  1WO_QJC_A,=-_Y]=>_\$=[_P#&
MJ .BHKG?^$QTW_GUU[_P1WO_ ,:H_P"$QTW_ )]=>_\ !'>__&J .BHKG?\
MA,=-_P"?77O_  1WO_QJC_A,=-_Y]=>_\$=[_P#&J .BHKG?^$QTW_GUU[_P
M1WO_ ,:H_P"$QTW_ )]=>_\ !'>__&J .BHKG?\ A,=-_P"?77O_  1WO_QJ
MC_A,=-_Y]=>_\$=[_P#&J .BHKG?^$QTW_GUU[_P1WO_ ,:H_P"$QTW_ )]=
M>_\ !'>__&J .BHKG?\ A,=-_P"?77O_  1WO_QJC_A,=-_Y]=>_\$=[_P#&
MJ .BHKG?^$QTW_GUU[_P1WO_ ,:H_P"$QTW_ )]=>_\ !'>__&J .BHKG?\
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M% !1110 4444 %%%% !1110 4444 ,FB2:)HYD62-AAD89##T(IR@*H X X
MI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@#F_#X_XJKQ1_P!=H/\ T2M=)7.>'_\
MD:O%'_7:#_T2M='0 4444 %%%% '%?\ -:!_V+__ +<UVM<5_P UH'_8O_\
MMS7:T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!SGA_P#Y&KQ1_P!=H/\
MT2M='7.>'_\ D:O%'_7:#_T2M='0 4F:6N8\>6UK<:;:M?WUK91PW'F W,9>
M.1MC *5#*3USUZB@#ILTM>76TMW*AD@@EMM>99#);QD[H[?[*=B@?W0^S'^U
M^-=1X),&[4/[-;=IN8O**DE=^W]Y@^N<9]Z *?\ S6@?]B__ .W-=K7F5XVO
M_P#"XY?LB:69?[&_=>:T@'E?:#][ ^]G'3CK73[O&7_//P]_W\F_^)H Z:BN
M9W>,O^>?A[_OY-_\31N\9?\ //P]_P!_)O\ XF@#IJ*YG=XR_P">?A[_ +^3
M?_$T;O&7_//P]_W\F_\ B: .FHKF=WC+_GGX>_[^3?\ Q-&[QE_SS\/?]_)O
M_B: .FHKF=WC+_GGX>_[^3?_ !-&[QE_SS\/?]_)O_B: .FHKF=WC+_GGX>_
M[^3?_$T;O&7_ #S\/?\ ?R;_ .)H Z:BN9W>,O\ GGX>_P"_DW_Q-&[QE_SS
M\/?]_)O_ (F@#IJ*YG=XR_YY^'O^_DW_ ,31N\9?\\_#W_?R;_XF@#IJ*YG=
MXR_YY^'O^_DW_P 31N\9?\\_#W_?R;_XF@#IJ*YG=XR_YY^'O^_DW_Q-&[QE
M_P \_#W_ '\F_P#B: .FHKF=WC+_ )Y^'O\ OY-_\31N\9?\\_#W_?R;_P")
MH Z:BN9W>,O^>?A[_OY-_P#$T;O&7_//P]_W\F_^)H Z:BN9W>,O^>?A[_OY
M-_\ $T;O&7_//P]_W\F_^)H Z:BN9W>,O^>?A[_OY-_\31N\9?\ //P]_P!_
M)O\ XF@#IJ*YG=XR_P">?A[_ +^3?_$T;O&7_//P]_W\F_\ B: .FHKF=WC+
M_GGX>_[^3?\ Q-&[QE_SS\/?]_)O_B: .FHKF=WC+_GGX>_[^3?_ !-&[QE_
MSS\/?]_)O_B: .FHKF=WC+_GGX>_[^3?_$T;O&7_ #S\/?\ ?R;_ .)H Z:B
MN9W>,O\ GGX>_P"_DW_Q-&[QE_SS\/?]_)O_ (F@#IJ*YG=XR_YY^'O^_DW_
M ,31N\9?\\_#W_?R;_XF@#IJ*YG=XR_YY^'O^_DW_P 31N\9?\\_#W_?R;_X
MF@#IJ*YG=XR_YY^'O^_DW_Q-&[QE_P \_#W_ '\F_P#B: .FHKF=WC+_ )Y^
M'O\ OY-_\31N\9?\\_#W_?R;_P")H Z:BN9W>,O^>?A[_OY-_P#$T;O&7_//
MP]_W\F_^)H Z:BN9W>,O^>?A[_OY-_\ $T;O&7_//P]_W\F_^)H Z:BN9W>,
MO^>?A[_OY-_\31N\9?\ //P]_P!_)O\ XF@#IJ*YG=XR_P">?A[_ +^3?_$T
M;O&7_//P]_W\F_\ B: .FHKF=WC+_GGX>_[^3?\ Q-&[QE_SS\/?]_)O_B:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G/#_\
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M@[]WXXQ5S_A7D'_0R^+O_!S+_C0!VU%<3_PKR#_H9?%W_@YE_P :/^%>0?\
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M!_T,OB[_ ,',O^-'_"O(/^AE\7?^#F7_ !H [:BN)_X5Y!_T,OB[_P ',O\
MC1_PKV ?\S+XN_\ !S+_ (T =M17GMA\/)A<7_VWQ/XI,)GS:A-8ERL7EIPW
MOO\ ,_ BKG_"O(/^AE\7?^#F7_&@#MJ*XG_A7D'_ $,OB[_P<R_XT?\ "O(/
M^AE\7?\ @YE_QH [:BN)_P"%>0?]#+XN_P#!S+_C0?A[ /\ F9?%W_@YE_QH
M T_#_P#R-7BC_KM!_P"B5KHZY;P5X;D\.S:UYM[=WJW=TLD,EW<-/+Y8B1<,
MQYSN#_ABNIH ***#0 5FZMJ4-K)%8K<V\.I7D<GV-)\[9'4#TZXR..OI3-;U
MRVT<(;F.YD!!=O(B+^6@P"[>BC(]_;@UR-O;R7=Y;:=JGVRZFG9H[R.4,RK@
M%EN;>7'R+D+P#QD<!AR ;.@ZGJ<=Y9:=JUKL>:)VW-.LDP92-S.%&T(23MQT
MX&!G ZJJMC:FW@B6:0W%PD:QM<.H#R8[G'Y_C5J@ HHHH *H7VIVUM=063W$
M,=]=*YMHY#CS"H&?YBH-;UVVT<Q_:4N) PW.88BXB0$ N_HHR/?KQP<<C:PR
MW5Y:Z?J8O+J>=FCO8Y59E0A2RW,$N/D7<JX .!D<!AR 7_"'B&\N;J"PNXLO
M^\CE620FYBD3EFD7& A)^4@XP5QP>.U%5[*W-O;QK+(9YE14:9U :3'<XJQ0
M 4444 %9FJ:E%%<)IT-W;PZI<QLULDP)#8QDX[XST[_G46MZ[;:2R).MPQ8;
MF>*(NL*DXWOZ+G\?; )')V=K)>W5OINI_;IYY=R7BS EH)$4LMS!+CA2P  !
MQEAP"&% '3>'7N+:YOM+OKB:YEMV$L4\V-TL;\\XP.&#C@8 P*WJAM86BMXD
MED,\R($:9E 9R.YQQSUJ:@ HHHH *R=7U-(Y'TVTN;=-9F@>6UAE.-^._P"=
M,U[78-+80R"?S'7)E2(ND )VAW/9=W''/X9-<I9VKW]W!IM^-0DFD#"Z$X)D
MM)D&Y9X9L8V%N@!QEA@##"@"_P""]>OI[Z73=0W3L))]LKR(TT0C95*RJBA5
MRQ;:1U 'UKM14%K;B&,;B))BJB2;:%:0@8R<5/0 444&@ K'UW4_*$^GZ=-#
M_;;VS36\$AP7 .,C/!_SGBH]>UR+3F^S?OEGD3_7+$7CMRQVHTA[#=]?? YK
MFK"W;4+V+3[O^T#*T;-.9P3+8SI@K)'-CE&).!DCT &X  U?">J:A+JEU8:B
MMR\?EB>![I$2=5SM(D5/E&6SM( R >.YZRHH(5C&X[6E*@/)M +X'4XJ6@ H
MHHH *PO$&MQVRS6-G*O]K/'B!&0E?,()52V-H8X. Q&<4NO:Y%8,;4&99Y$P
M)UB+16Y8[4:0]@6^OO@<UR:1:C>O#IUH]P+HM'<7*ZA&S_9IX9$8,'_B1\'
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MY93EF8G)/H!D\ < <"FZ=:?8[81&>>X8DL\L[ N['J3@ #Z  #L*M4 %%%%
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MDM+,VYW).23T'4]  !T  JU0 4444 %4=5O!:PHJ,/M,[>5;J5)W28) ..V
M23V -3WZ3264Z6L@CN&C98G(R%8C@_G7GEMHPO+S14M+;5=)U.WE:34)55@H
M/E.-X=@8Y&+D8/S95F!'44 :^[5=?M;K3+UH-.U"*.)V"Q-(%E5PV]6. R<#
M;W/.<8(KK+&W-K:QPF668H,&25MS,>Y)I+&U%G:QP++++MR3)*VYV).22?J>
MW'H *L4 %%%% !5'5[PVT"QP%?MEP3';*RDAGP3SCHHQR>U2:G%/-IUU'9R"
M*Y>)EB<_PL1P?SK@K71H[O4M(73;;5M)OH"S7TH1E"GRV&X.X,<CER!D;@5+
M9Z"@#5!U/Q#;3V%V\.G7]N;>5E$+2!)4D#EP3A60[1M[^N.1766<'V6UCA\R
M678N-\K;F;W)]:2QMA9VJ0+)+(%'+RMN9B>22?4FIZ "BBB@ K/U>\-M$L<!
M3[;<9CMD920SX)YQT48Y-3:K'<2Z;=1V4@BNGB98G/16QP?SK@K31H[S4=)&
MFVVK:/>6^]KZ0(RA6V$9#N"DC%L<C<""<]!@ U0=3\16LUC=/%IU];/;2LJP
ML^V5) Y8$X5E.WY?S/.1766D'V:VBA$DLHC4+OE?<S>Y/<TEE;+:VL<*O+($
M'WY6+,Q[DD]ZGH **** #-9VM7CV\ @LS&=1G5A:I(K%2P&<MCD*.,GW'<BI
M=8BN9M*O(["01W;Q,L3G^%L<5PUIHT-YK&FG1[?5M%D@CD^UN$9 C$ ##."D
MC$]2 P(Y/1: -/&I^([:XLYY8M-O+:6VDP(&=HW1U=FR?E8-@A<9XY/H.MM8
M1;VT4(>201J%WR.69L=R3U-)9VZVMM' C2.J+C=(Q9C[DGJ:FH **** "DQ1
M10 O2BBB@ HHHH ",TF*** %HHHH **** "DQ110 M%%% !1110 $9HQ110
M4444 %%%% !28%%% "T444 %%%% !UHQ110 4444 %%%% !28HHH 6BBB@ H
MHHH ",T8HHH **** "BBB@ HQ110 4444 %%%% !UI,444 +1110 4444 %&
.*** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Submission<br></strong></div></th>
<th class="th"><div>Oct. 16, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissionLineItems', window );"><strong>Submission [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Central Index Key</a></td>
<td class="text">0000947263<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Registrant Name</a></td>
<td class="text">TORONTO DOMINION BANK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_RegnFileNb', window );">Registration File Number</a></td>
<td class="text">333-283969<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FormTp', window );">Form Type</a></td>
<td class="text">F-3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_SubmissnTp', window );">Submission Type</a></td>
<td class="text">424B3<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeeExhibitTp', window );">Fee Exhibit Type</a></td>
<td class="text">EX-FILING FEES<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OfferingTableNa', window );">Offering Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_OffsetTableNa', window );">Offset Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_CombinedProspectusTableNa', window );">Combined Prospectus Table N/A</a></td>
<td class="text">N/A<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_CombinedProspectusTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_CombinedProspectusTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeeExhibitTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeeExhibitTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:feeExhibitTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FormTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FormTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OfferingTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OfferingTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_OffsetTableNa">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_OffsetTableNa</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:naItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_RegnFileNb">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_RegnFileNb</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_SubmissnTp">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_SubmissnTp</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.3</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fees Summary<br></strong></div></th>
<th class="th">
<div>Oct. 16, 2025 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FeesSummaryLineItems', window );"><strong>Fees Summary [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvDsclsr', window );">Narrative Disclosure</a></td>
<td class="text"><div style="text-align: center; font-family: Arial; font-size: 12pt;">The maximum aggregate offering price of the securities to which the prospectus relates is $62,000.00. The prospectus is a final prospectus for the related offering<span>.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_NrrtvMaxAggtOfferingPric', window );">Narrative - Max Aggregate Offering Price</a></td>
<td class="nump">$ 62,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ffd_FnlPrspctsFlg', window );">Final Prospectus</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FeesSummaryLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FeesSummaryLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_FnlPrspctsFlg">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_FnlPrspctsFlg</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvDsclsr">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvDsclsr</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ffd_NrrtvMaxAggtOfferingPric">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ffd_NrrtvMaxAggtOfferingPric</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ffd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>ffd:nonNegative100TMonetary2ItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>12</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995210 - Document - Submission</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/submissionTable</Role>
      <ShortName>Submission</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="exfilingfees.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995215 - Document - Fees Summary</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ffd/role/document/feesSummaryTable</Role>
      <ShortName>Fees Summary</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="EX-FILING FEES" original="exfilingfees.htm">exfilingfees.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="2">http://xbrl.sec.gov/dei/2025</BaseTaxonomy>
    <BaseTaxonomy items="10">http://xbrl.sec.gov/ffd/2025</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>false</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "exfilingfees.htm": {
   "dts": {
    "inline": {
     "local": [
      "exfilingfees.htm"
     ]
    },
    "schema": {
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/arcrole/deprecated-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd",
      "https://xbrl.sec.gov/dei/2025/dei-2025.xsd",
      "https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
     ]
    }
   },
   "keyStandard": 12,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 7,
    "http://xbrl.sec.gov/ffd/2025": 6,
    "http://xbrl.sec.gov/dei/2025": 1
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 107,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ffd/2025": 10,
    "http://xbrl.sec.gov/dei/2025": 2
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/ffd/role/document/submissionTable",
     "longName": "995210 - Document - Submission",
     "shortName": "Submission",
     "isDefault": "true",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable",
     "longName": "995215 - Document - Fees Summary",
     "shortName": "Fees Summary",
     "isDefault": "false",
     "groupType": "Fee_Exhibit",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c0",
      "name": "ffd:NrrtvDsclsr",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "div",
       "div",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "exfilingfees.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ffd_AggtRedRpPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtRedRpPricPrrFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtRedRpPricPrrFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Redeemed or Repurchased Price, Prior Fiscal Year",
        "terseLabel": "Aggregate Redeemed or Repurchased, Prior FY"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AggtSalesPricFsclYr": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AggtSalesPricFsclYr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Sales Price, Fiscal Year",
        "terseLabel": "Aggregate Sales Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtRedCdts": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtRedCdts",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Redemption Credits",
        "terseLabel": "Redemption Credits"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_AmtSctiesRcvd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Received",
        "terseLabel": "Amount of Securities Received",
        "documentation": "Amount of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_AmtSctiesRegd": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "AmtSctiesRegd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amount of Securities Registered",
        "terseLabel": "Amount Registered",
        "documentation": "The amount of securities being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CeasedOprsDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CeasedOprsDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Ceased Operations Date",
        "terseLabel": "Ceased Operations Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CfwdFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Form Type",
        "terseLabel": "Carry Forward Form Type",
        "documentation": "The Form Type of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrevslyPdFee": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrevslyPdFee",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Previously Paid Fee",
        "terseLabel": "Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward",
        "documentation": "The fee previously paid in connection with the securities being brought forward from the prior shelf registration statement on which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward Prior Effective Date",
        "terseLabel": "Carry Forward Initial Effective Date",
        "documentation": "The initial effective date of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CfwdPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CfwdPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Carry Forward File Number",
        "terseLabel": "Carry Forward File Number",
        "documentation": "The EDGAR File Number of the prior shelf registration statement from which unsold securities are carried forward under 415(a)(6). If the prior registration statement has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_CmbndPrspctsItemAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsItemAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Item [Axis]",
        "terseLabel": "Combined Prospectus",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different references to earlier prospectuses on a single fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Line Items]",
        "terseLabel": "Combined Prospectus:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CmbndPrspctsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CmbndPrspctsTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus [Table]",
        "terseLabel": "Combined Prospectus Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_CombinedProspectusTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CombinedProspectusTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Combined Prospectus Table [N/A]",
        "terseLabel": "Combined Prospectus Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_CshPdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshPdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Paid by Registrant in Transaction",
        "terseLabel": "Cash Consideration Paid",
        "documentation": "Amount of cash consideration paid by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "ffd_CshRcvdByRegistrantInTx": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "CshRcvdByRegistrantInTx",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Received by Registrant in Transaction",
        "terseLabel": "Cash Consideration Received",
        "documentation": "Amount of cash consideration received by registrant in connection with the exchange or other transaction being registered (in a 457(f) calculation)."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2025",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "ffd_FeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Amount",
        "terseLabel": "Amount of Registration Fee",
        "documentation": "Total amount of registration fee (amount due after offsets)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeExhibitTp": {
     "xbrltype": "feeExhibitTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeExhibitTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Exhibit Type",
        "terseLabel": "Fee Exhibit Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_FeeIntrstAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Interest Amount",
        "terseLabel": "Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note",
        "terseLabel": "Fee Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeNoteMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeNoteMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Note Maximum Aggregate Offering Price",
        "terseLabel": "Fee Note MAOP"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeeRate": {
     "xbrltype": "percentItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeeRate",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Rate",
        "terseLabel": "Fee Rate",
        "documentation": "The rate per dollar of fees that public companies and other issuers pay to register their securities with the Commission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesOthrRuleFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesOthrRuleFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees, Other Rule [Flag]",
        "terseLabel": "Other Rule",
        "documentation": "Checkbox indicating whether filer is using a rule other than 457(a), 457(o), or 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FeesSummaryLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FeesSummaryLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Fees Summary [Line Items]",
        "terseLabel": "Fees Summary:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FnlPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FnlPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Final Prospectus [Flag]",
        "terseLabel": "Final Prospectus"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_FormTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "FormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Form Type",
        "terseLabel": "Form Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_GnlInstrIIhiFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "GnlInstrIIhiFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "General Instruction II.H,I [Flag]",
        "terseLabel": "General Instruction II.H,I"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrCity": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrCity",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, City",
        "terseLabel": "City"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStatOrCtryCd": {
     "xbrltype": "stateOrCountryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStatOrCtryCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, State or Country Code",
        "terseLabel": "State or Country Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt1": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt1",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 1",
        "terseLabel": "Street 1"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrStrt2": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrStrt2",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Street 2",
        "terseLabel": "Street 2"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrBizAdrZipCd": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrBizAdrZipCd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Business Address, Zip Code",
        "terseLabel": "Zip Code"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_IssrNm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "IssrNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Issuer Name",
        "terseLabel": "Issuer Name"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_MaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Aggregate Offering Price",
        "terseLabel": "Maximum Aggregate Offering Price",
        "documentation": "The maximum aggregate offering price for the offering that is being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_MaxOfferingPricPerScty": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "MaxOfferingPricPerScty",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum Offering Price per Security",
        "terseLabel": "Proposed Maximum Offering Price per Unit",
        "documentation": "The maximum offering price per share/unit being registered."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetFeeAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Fee Amount",
        "terseLabel": "Net Fee"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NetSalesAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NetSalesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Sales Amount",
        "terseLabel": "Net Sales"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvDsclsr": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvDsclsr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure",
        "terseLabel": "Narrative Disclosure"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Amount",
        "terseLabel": "Narrative - Max Aggregate Offering Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_NrrtvMaxAggtOfferingPric": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "NrrtvMaxAggtOfferingPric",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Narrative Disclosure, Maximum Aggregate Offering Price",
        "terseLabel": "Narrative - Max Aggregate Offering Price"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Axis]",
        "terseLabel": "Offering",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different security offerings on a single fee bearing submission."
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Line Items]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Note",
        "terseLabel": "Offering Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Title",
        "terseLabel": "Security Class Title",
        "documentation": "The title of the class of securities being registered (for each class being registered)."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Security Type",
        "terseLabel": "Security Type",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OfferingTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering [Table]",
        "terseLabel": "Offering:"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OfferingTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OfferingTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offering Table [N/A]",
        "terseLabel": "Offering Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_OffsetAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset [Axis]",
        "terseLabel": "Offset",
        "documentation": "A sequence number (1, 2, 3...) used to distinguish different offsets as applied to a fee bearing submission."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetClmInitlFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmInitlFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claim Initial Filing Date",
        "terseLabel": "Initial Filing Date",
        "documentation": "The initial filing date of the earlier registration statement with which the earlier (offsetting) fee was paid for a claimed offset. If the offset fee was paid with an amendment, do not provide the amendment date under this element; instead, provide the date of the initial filing (i.e. the \"parent\" filing) ."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Amount",
        "terseLabel": "Fee Offset Claimed",
        "documentation": "The amount of offsetting fees being claimed."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetClmdInd": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetClmdInd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Claimed Indicator",
        "terseLabel": "Offset Claimed"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetExpltnForClmdAmt": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetExpltnForClmdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Explanation for Claimed Amount",
        "terseLabel": "Explanation for Claimed Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetLineItems",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset:",
        "label": "Offset [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Note",
        "terseLabel": "Offset Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetPrrFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Fee Amount",
        "terseLabel": "Fee Paid with Fee Offset Source",
        "documentation": "The fee previously paid from which an offset is being derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior File Number",
        "terseLabel": "File Number",
        "documentation": "The EDGAR File Number of the earlier registration statement with which the earlier (offsetting) fee was paid. If the offset filing for the offset has a Securities Act File Number and an Investment Company Act File Number, the Securities Act File Number should be used."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFilerNm": {
     "xbrltype": "filerNameItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFilerNm",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Filer Name",
        "terseLabel": "Registrant or Filer Name",
        "documentation": "The name of the registrant that filed the earlier registration statement with which the earlier (offsetting) fee was paid."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Form Type",
        "terseLabel": "Form or Filing Type",
        "documentation": "The Form Type of the offset filing."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrNbOfUnsoldScties": {
     "xbrltype": "nonNegativeIntegerItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrNbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Number of Securities",
        "terseLabel": "Unsold Securities Associated with Fee Offset Claimed",
        "documentation": "The number of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Title",
        "terseLabel": "Security Title Associated with Fee Offset Claimed",
        "documentation": "The title of the class of securities from which offset fees were derived."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrSctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrSctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Security Type",
        "terseLabel": "Security Type Associated with Fee Offset Claimed",
        "documentation": "Type of securities: \"Asset-backed Securities\", \"ADRs/ADSs\", \"Debt\", \"Debt Convertible into Equity\", \"Equity\", \"Face Amount Certificates\", \"Limited Partnership Interests\", \"Mortgage Backed Securities\", \"Non-Convertible Debt\", \"Unallocated (Universal) Shelf\", \"Exchange Traded Vehicle Securities\", \"Other\""
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetPrrUnsoldOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetPrrUnsoldOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Prior Unsold Offering Amount",
        "terseLabel": "Unsold Aggregate Offering Amount Associated with Fee Offset Claimed",
        "documentation": "The aggregate offering amount of unsold securities registered on the prior registration statement that are associated with the claimed offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetSrcFilgDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetSrcFilgDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Source Filing Date",
        "terseLabel": "Filing Date",
        "documentation": "The filing date of the earlier registration statement with which the earlier (offsetting) fee was paid in an offset."
       }
      }
     },
     "auth_ref": [
      "r5",
      "r8"
     ]
    },
    "ffd_OffsetTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Offset Payment:",
        "label": "Offset [Table]"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_OffsetTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "OffsetTableNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Offset Table [N/A]",
        "terseLabel": "Offset Table N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_PrevslyPdFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "PrevslyPdFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable",
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fee Previously Paid [Flag]",
        "terseLabel": "Fee Previously Paid"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RegnFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RegnFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration File Number",
        "terseLabel": "Registration File Number"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_RptgFsclYrEndDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "RptgFsclYrEndDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Reporting Fiscal Year End Date",
        "terseLabel": "Reporting FY End Date"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 0-11 [Flag]",
        "terseLabel": "Rule 0-11"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule011a2OffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule011a2OffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Rule 0-11(a)(2) Offset",
        "label": "Rule 0-11(a)(2) Offset [Flag]"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_Rule415a6Flg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule415a6Flg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 415(a)(6) [Flag]",
        "terseLabel": "Rule 415(a)(6)",
        "documentation": "Checkbox indicating whether filer is claiming a 415(a)(6) carryforward."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "ffd_Rule429AggtOfferingAmt": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429AggtOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Aggregate Offering Amount",
        "terseLabel": "Maximum Aggregate Offering Price of Securities Previously Registered",
        "documentation": "The maximum aggregate offering amount of unsold securities registered on the prior registration statement that are carried forward under Rule 429. Only applicable if 457(o) was used in the fee calculation for the prior registration statement."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429CmbndPrspctsFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429CmbndPrspctsFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Combined Prospectus [Flag]",
        "terseLabel": "Rule 429",
        "documentation": "Checkbox indicating whether filer is using a combined prospectus under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFileNb": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFileNb",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier File Number",
        "terseLabel": "File Number",
        "documentation": "The Securities Act File Number of the earlier effective registration statement(s) from which securities may be offered and sold using the combined prospectus pursuant to Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429EarlierFormTp": {
     "xbrltype": "formTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429EarlierFormTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Earlier Form Type",
        "terseLabel": "Form Type",
        "documentation": "The Form Type of the earlier registration statement from which unsold securities are carried forward under Rule 429. This should be an EDGAR submission type (S-3, S-3/A, S-3ASR, etc.), which means there is a fixed set of possible responses. Note that while the XBRL response should be an EDGAR submission type, the human-readable Ex. 107 could include a simpler label (e.g., \"Form S-3\" in the human-readable and \"S-3ASR\" in the XBRL)."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429InitlFctvDt": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429InitlFctvDt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Initial Effective Date",
        "terseLabel": "Initial Effective Date",
        "documentation": "The filing date of the earlier registration statement from which unsold securities are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429NbOfUnsoldScties": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429NbOfUnsoldScties",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Number Of Unsold Securities",
        "terseLabel": "Amount of Securities Previously Registered",
        "documentation": "The number of securities registered on the prior registration statement that are carried forward under Rule 429."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "ffd_Rule429PrspctsNote": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429PrspctsNote",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Prospectus Note",
        "terseLabel": "Combined Prospectus Note"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTitl": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTitl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Title",
        "terseLabel": "Security Class Title"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule429SctyTp": {
     "xbrltype": "securityTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule429SctyTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesByCmbndPrspctsTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 429 Security Type",
        "terseLabel": "Security Type"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Rule457aFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457aFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(a) [Flag]",
        "terseLabel": "Rule 457(a)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(a) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "ffd_Rule457bOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457bOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(b) Offset [Flag]",
        "terseLabel": "Rule 457(b) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(b) or 0-11(a)(2)."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "ffd_Rule457fFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457fFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(f) [Flag]",
        "terseLabel": "Rule 457(f)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(f) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_Rule457oFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457oFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(o) [Flag]",
        "terseLabel": "Rule 457(o)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(o) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "ffd_Rule457pOffsetFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457pOffsetFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(p) Offset [Flag]",
        "terseLabel": "Rule 457(p) Offset",
        "documentation": "Checkbox indicating whether filer is claiming an offset under Rule 457(p)."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "ffd_Rule457rFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457rFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(r) [Flag]",
        "terseLabel": "Rule 457(r)"
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "ffd_Rule457sFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457sFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(s) Flag",
        "terseLabel": "Rule 457(s)"
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "ffd_Rule457uFlg": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Rule457uFlg",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 457(u) [Flag]",
        "terseLabel": "Rule 457(u)",
        "documentation": "Checkbox indicating whether filer is using Rule 457(u) to calculate the registration fee due."
       }
      }
     },
     "auth_ref": [
      "r11"
     ]
    },
    "ffd_Scties424iAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iAxis",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Axis]",
        "terseLabel": "Securities, 424I"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Line Items]",
        "terseLabel": "Securities, 424I:"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Scties424iTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Scties424iTable",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/securities424iTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities, 424I [Table]",
        "terseLabel": "Securities, 424I Table"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_Securities424iTableNa": {
     "xbrltype": "naItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "Securities424iNa",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Securities 424I [N/A]",
        "terseLabel": "Securities 424I N/A"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissionLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissionLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission [Line Items]",
        "terseLabel": "Items"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_SubmissnTp": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "SubmissnTp",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/submissionTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Submission Type",
        "terseLabel": "Submission Type"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TermntnCmpltnWdrwl": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TermntnCmpltnWdrwl",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOffsetTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination / Completion / Withdrawal Statement",
        "terseLabel": "Termination / Withdrawal Statement"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_TtlFeeAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee Amount",
        "terseLabel": "Total Fee Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlFeeAndIntrstAmt": {
     "xbrltype": "nonNegativeDecimal2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlFeeAndIntrstAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Fee and Interest Amount",
        "terseLabel": "Total Fee and Interest Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOfferingAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOfferingAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offering Amount",
        "terseLabel": "Total Offering"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlOffsetAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlOffsetAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Offset Amount",
        "terseLabel": "Total Offset Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlPrevslyPdAmt": {
     "xbrltype": "nonNegative1TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlPrevslyPdAmt",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Previously Paid Amount",
        "terseLabel": "Previously Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TtlTxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TtlTxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesSummaryTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Transaction Valuation",
        "terseLabel": "Total Transaction Valuation"
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "ffd_TxValtn": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "TxValtn",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Transaction Valuation",
        "terseLabel": "Transaction Valuation"
       }
      }
     },
     "auth_ref": []
    },
    "ffd_ValSctiesRcvd": {
     "xbrltype": "nonNegative100TMonetary2ItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvd",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received",
        "terseLabel": "Value of Securities Received",
        "documentation": "Value of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form)"
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "ffd_ValSctiesRcvdPerShr": {
     "xbrltype": "nonNegativeDecimal4lItemType",
     "nsuri": "http://xbrl.sec.gov/ffd/2025",
     "localname": "ValSctiesRcvdPerShr",
     "presentation": [
      "http://xbrl.sec.gov/ffd/role/document/feesOfferingTable"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Value of Securities Received, Per Share",
        "terseLabel": "Value of Securities Received, Per Share",
        "documentation": "Value per share of securities to be received by the registrant (or cancelled upon issuance of securities to be registered on the form). This is included in the explanation of 457(f) fee calculation."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "415",
   "Subsection": "a"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "429"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "f"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "o"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "p"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "r"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "s"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "457",
   "Subsection": "u"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Subsection": "f",
   "Section": "457"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001140361-25-038671-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-25-038671-xbrl.zip
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@;F=F965S+FAT;5!+!08      0 ! #X   !I"      !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>exfilingfees_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ffd="http://xbrl.sec.gov/ffd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef
      xlink:href="https://xbrl.sec.gov/ffd/2025/ffd-2025.xsd"
      xlink:type="simple"/>
    <context id="c0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000947263</identifier>
        </entity>
        <period>
            <startDate>2025-10-16</startDate>
            <endDate>2025-10-16</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <ffd:FormTp contextRef="c0" id="ixv-32">F-3</ffd:FormTp>
    <dei:EntityRegistrantName contextRef="c0" id="ixv-33">TORONTO DOMINION BANK</dei:EntityRegistrantName>
    <ffd:NrrtvDsclsr contextRef="c0" id="ixv-26">&lt;div style="text-align: center; font-family: Arial; font-size: 12pt;"&gt;The maximum aggregate offering price of the securities to which the prospectus relates is $62,000.00. The prospectus is a final prospectus for the related offering&lt;span&gt;.&lt;/span&gt;&lt;/div&gt;</ffd:NrrtvDsclsr>
    <ffd:NrrtvMaxAggtOfferingPric contextRef="c0" decimals="2" id="ixv-34" unitRef="usd">62000</ffd:NrrtvMaxAggtOfferingPric>
    <ffd:FnlPrspctsFlg contextRef="c0" id="ixv-35">true</ffd:FnlPrspctsFlg>
    <ffd:CombinedProspectusTableNa contextRef="c0" id="ixv-38">N/A</ffd:CombinedProspectusTableNa>
    <dei:EntityCentralIndexKey contextRef="c0" id="ixv-39">0000947263</dei:EntityCentralIndexKey>
    <ffd:FeeExhibitTp contextRef="c0" id="ixv-40">EX-FILING FEES</ffd:FeeExhibitTp>
    <ffd:OfferingTableNa contextRef="c0" id="ixv-41">N/A</ffd:OfferingTableNa>
    <ffd:OffsetTableNa contextRef="c0" id="ixv-42">N/A</ffd:OffsetTableNa>
    <ffd:RegnFileNb contextRef="c0" id="ixv-43">333-283969</ffd:RegnFileNb>
    <ffd:SubmissnTp contextRef="c0" id="ixv-44">424B3</ffd:SubmissnTp>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
